Loyola University Chicago

Loyola eCommons
Master's Theses

Theses and Dissertations

1979

Fat-Mobilizing Substance (FMS)
Dorothy A. Krupa
Loyola University Chicago

Follow this and additional works at: https://ecommons.luc.edu/luc_theses
Part of the Medicine and Health Sciences Commons

Recommended Citation
Krupa, Dorothy A., "Fat-Mobilizing Substance (FMS)" (1979). Master's Theses. 3034.
https://ecommons.luc.edu/luc_theses/3034

This Thesis is brought to you for free and open access by the Theses and Dissertations at Loyola eCommons. It
has been accepted for inclusion in Master's Theses by an authorized administrator of Loyola eCommons. For more
information, please contact ecommons@luc.edu.
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.
Copyright © 1979 Dorothy A. Krupa

FAT-HOBILIZING SUBSTANCE (FMS)

by
Dorothy A. Krupa

A Thesis Submitted to the Faculty of the Graduate School
of Loyola University of Chicago in Partial Fulfillment
of the Requirements for the Degree of
Master of Science
January
1979

ACKNm'VLEDGEMENT S
The author is indebeted to Dr. Maurice V. L'Heureux
for his continued guidance, support, and encouragement
extending from the beginning of this study to its completion.

His integrity as a teacher, advisor, and a citizen

have made an indelible impression upon the author.
The author is very grateful to all members of the
Department of Biochemistry and Biophysics of Loyola
University who have contributed to the author's work by
exchange of ideas and also wishes to express her thanks
to Dr. Peter R. Oeltgen for his most helpful assistance.
Finally, the author wants to express her deep
appreciation to her family who patiently endured the many
evenings and weekends that were devoted to this study.

ii

VITA
The author, Dorothy A. Krupa, is the daughter of
Walter R. Kulpinski and Mildred (Bowbin) Kulpinski.

She

was born in Chicago, Illinois.
Her elementary education was obtained in the schools
of Chicago, and secondary education at the Carl Schurz High
School of Chicago from which she graduated in 1965.
In the Fall of 1968 she was accepted as a student at
Roosevelt University of Chicago, and in September 1972
received the degree of Bachelor of Science with a major in
psychology.

While attending Roosevelt University she was

a teaching assistant in genetics in the fall of 1970. ·
In the summer of 1973, she entered the Department of
Biochemistry and Biophysics, Loyola University of Chicago
as a graduate student.

In 1974 she was employed as a

research assistant in the Department of Pathology of
Loyola University at the Medical Center.

iii

TABLE OF CONTENTS
Page
ACKNOWLEDGI.-1ENTS . . . . . . . . . . . . • . . . . . . • . . . . . . . . . . . . . • .

ii

VITA. . • . . . . . . . . . . . . • • . • . . . • • • • . . . . • . • • . • • . • . . • . . • . iii
LIST OF TABLES ...•....•••..............•••.....•.. vii
LIST OF FIGURES. . • . . • . . • . . . • • . . • . . • . . . . . • . . . . . . . • .

ix

Chapter
I.

II.

INTRODUCTION . . • . . . . • . . . . • . . . • . . . . . . . . . . • • •

1

Dietary Aspects and Application of
Stress in Conditions in which FMS
Activity is Found • • . . • • . • . . • • . • . . • . . . . .

4

Sex, Age, Il1etabolic Obesity and
Weight Reduction •.•.•....•.••.........•

12

FMS and Pituitary Hormones .•...••...••.

16

Mode of Lipolytic Action of FMS •.••..•.

22

Mechanism of Action .•.....•.........••.

27

Isolation and Purification of FMS ..•..•

29

Chemical Nature of FMS ...•..•.....•..•.

31

Statement of the Problem .....•...•.•••.

33

MATERIALS AND HETHODS . . . . . . • . • • • . . • . • . • . . .

35

General Experimental Procedures .....•..

35

Chemicals . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

39

Urine Collection and Extraction of
Crude FMS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

42

Free Fatty Acid Determination . . . . . . . . . .

46

Determination of the Biological Activity
of FMS Based on FFA Release from
Epididymal Fat Pads . . . . . . . . . . . . . . . . . . . .
49
iv

Chapter

Page
Preparation of Isolated Fat Cells •.•...

52

Determination of the Biological Activity
of FMS Based on FFA Release from
Epididymal Fat Cells ........••....•...• 55
Extraction of Total Lipid from Fat
Cell Suspensions ......•••..........••.•

57

Determination of Adipose Cell Size
and Number. . . . . . . . . . . . . . . . . . . . . . . . . . . . .

58

Preparation of Adipocytes .•.•..•...•••.

61

Glycerol Determination ...•..•••..•..•.•

62

Determination of Biological Activity
of FMS Based on Glycerol Release from
Epididymal Fat Cells ....•...•••••...•.•

66

Purification of Crude FMS by Ultrafiltration and Column Chromatography ...•.•

71

Isoelectric Focusing .•...••.•.••••.•..•

74

Protein Determination •....•....•.•..•..

86

Polyacrylamide Gel Electrophoresis of
F~1.S

III.

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

91

RESULTS... • . . . . . . . . . . . . . • . . . . . . . . . . . . . • • . . . • 101
Effect of Body Weight and Age of the
Rat on the Bulk Urinary Excretion,
Total, and Specific Activity of FMS .... 101
Purification of FMS by Ultrafiltration. 113
Purification of Fl'1S by Gel Filtration .. 120
Isoelectric Focusing of FMS . . . . . . . . . . . . 129
In Vitro Bioassay of FMS Fraction I,
FMS Fraction II, and FHS Fraction III .. 133
Determination of Total Protein Content
of FMS Fraction I, FMS Fraction II, and
FMS Fraction III . . . . . . . . . . . . . . . . . . . . . . . 138
v

Page

Chapter
Polyacrylamide Gel Electrophoresis
of Fi4S.................................

138

IV.

DISCUSSION AND CONCLUSIONS ••••••••••••••••••

149

V.

SUJ11MARY.....................................

167

VI.

BIBLIOGRAPHY.. • • • • • • • • • • • • • • • • • • • • • • • • • • • • • •

171

vi

LIST OF TABLES
Table
1.
2.
3.

Page
Constituents and Caloric Content of the
Higl1 Fat Diet...............................

43

Standard Curve Data for Determination of
Free Fatty Acids............................

50

Standard Curve Data for Determination of
Glycerol.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

68

4.

Protocol for the In Vitro Bioassay of FMS ..•

70

5.

Standard Curve Data for Determination of
Protein Concentration .....•.....•....•...•..

89

6.

Anionic Gel Stock Solutions .•...•.•......•..

92

7.

Anionic Gel

Solutions...............

93

8.

Fixative, Staining and Destaining Solutions.

94

9.

Response of Adipose Tissue to FMS Isolated
from Rats of Different Weight and Age ....... 103

10.

Effect of Weight and Age on the Bulk
Excretion of FMS .....•........•.•••.•••••... 104

11.

Effect of Weight and Age on the Specific
Activity of FHS .......••.......•.•.•••...... 105

12.

~vorking

Effect of Weight and Age on the Total Activity
of FMS.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 106

13.

Response of Adipocytes to FMS Isolated from
Rats of Different Weight and Age .........•.. 111

14.

Purification of FHS by Ultrafiltration •.•... 114

15.

Purification of FHS by DM-5 Ultrafiltration. 116

16.

Purification of FMS by Gel Filtration ....... 123

17.

Lipolytic Activity of Electrofocused Bands
from the Electrofocusing Column in which
FMS Preparations Have Been Resolved ......... 134
vii

Table

Page

18.

FFA Release as Index of Lipolytic
Activity of FMS at the Initial and Final
Stages of Purification .................... 136

19.

Glycerol Release as Index of Lipolytic
Activity of FMS at the Initial and Final
Stages of Purification .................... 137

20.

Response of Adipocytes to FMS at the
Initial and Final Stages of Purification .. 139

21.

Total Protein Content of
II,

22.

F~S

Fraction I,

and III . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 140

Specific Lipolytic Activity of FMS Fraction
I, FMS Fraction II, and FMS Fraction III
Protein... . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 141

viii

LIST OF FIGURES
Figure
1.

Page
Standard Curve for Determination of Free
Fatty Acids. . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . .

51

2.

Standard Curve for Determination of Glycerol ••

67

3.

Flow Diagram for Isolation and Purification

4.

of FMS • • • • • • • • • • • • • • • • • • . • • • • • • • • • • • • • • • • • • • • •

75

Standard Curve for Determination of Protein
Concentration •..•....••..••..•.....•.•••.....•

90

5.

Variation of Specific and Total Lipolytic
Activities with Rat Body Weight and Age .•.••.• 109

6.

Frequency Distribution of Adipose Cell
Diameters.... . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 112

7.

Top: Gel Filtration of UM-2 Residue on BioGel P-10. Bottom: Gel Filtration on Sephadex
G-50 Followed by Bio-Gel P-10 of a Combined
Preparation of Peak I and Peak II Previously
Fractionated by Passage of UM-2 Residue Through
the Column of Bio-Gel P-10 (top) •..•.......••• 122

8.

Gel Filtration of DM-5 Residue on Bio-Gel P-10 128

9.

Separation of FMS UM-2 Residue by LKB 8100
Ampholine Electrofocusing Column in which FMS
Fraction I, FMS Fraction II, and FMS Fraction
III Have Been Resolved ......•......•......•... 130

10.

Separation of FMS DM-5 Residue by LKB 8100
Ampholine Electrofocusing Column in which FMS
Fraction I and FMS Fraction II Have Been
Resolved. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 131

11.

Separation of the Active Eluant Peak Fraction
Obtained from Passage of FMS UM-2 Residue
Through a Sephadex G-50-Bio-Gel P-10 Column by
LKB 8100 Ampholine Electrofocusing Colu..mn in
which FMS Fraction I and FMS Fraction III Have
Been Resolved................................. 132

ix

Figure
12.

13.

14.

15.

16.

Page
Polyacrylamide Gel Electrophoretic Patterns
of (A) FMS Fraction II, (B) FMS Fraction III,
and (C) FMS Fraction I, with 250 ~g FMS Sample
Application...................................

143

Polyacrylamide Gel Electrophoretic Patterns
of (A) FMS Fraction II, (B) FMS Fraction III,
and (C) FMS Fraction I, with 150 ~g FMS Sample
Application...................................

144

Chart Record of Percent Transmittance from
Densicord Model 542 Densitometer Scan of FMS
Fraction I Electrophoresed Gel After Staining
with Coomassie Blue ....•......••.••••...••....

145

Chart Record of Percent Transmittance from
Densicord Model 542 Densitometer Scan of FMS
Fraction II Electrophoresed Gel After Staining
with Coomassie Blue ..........••.•.••.....•..••

146

Chart Record of Percent Transmittance from
Densicord Model 542 Densitometer Scan of FMS
Fraction III Electrophoresed Gel After Staining
with Coomassie Blue ...•.........••.•.•..••.... 147

X

CHAPTER I
INTRODUCTION
An agent of biological origin endowed with the
specific capacity of accelerating the mobilization of depot
fat was described by Best and Campbell (1936) as occurring
in the anterior pituitary gland.

This adipokinin (adipo-

kinetic substance) concentrated from aqueous extracts of
beef anterior pituitary glands by precipitation, at pH 5.2,
with 2 volumes of alcohol, upon injection into the fasted
mouse produced an increase in the quantity of liver fat
which was, within limits, linearly related to the dose
injected; moreover, it accelerated the mobilization of
depot fat and caused ketonemia.

Weil and Stetten (1947),

entertaining that variations might occur in the quantity
of adipokinetic substance released under conditions of
starvation or diabetes that might, in turn, be reflected by
variations in an analogous activity in the urine, used a
similar extraction procedure and were the first to show
that lipid mobilizing activity could be demonstrated in the
urine during fasting.

These authors found that an alkaline

extract of urine from fasting rabbits when injected into
mice caused an increase in liver fat.

Similarly prepared

extracts of urine from fed rabbits had no such effect.
Concurrently, it is still given to speculation, whether the

1
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adipokinetic activity demonstrated to occur in the urine
of the fasted rabbit is identical with that shown by Best
and Campbell (1936) to occur in the normal anterior pituitary gland.

However, during fasting and under conditions

in which an increase in the mobilization of depot fat might
be anticipated, there appears in the urine a material
capable of provoking such an increase, which at leastsuperficially resembles pituitary adipokinin (Weil and Stetten,
1947).
Chalmers et al.

(1958) extended these observations to

humans, based on studies on obese individuals.

It appeared

that a mechanism existed for controlling the mobilization of
depot fat which must be sensitive to changes in the composition as well as the caloric content of the diet.

Such a

mechanism should be operating at its maximum during fasting,
and if any hormonal agent were involved it should be detectable in the urine (Chalmers et al., 1958).
Therefore, Chalmers et al.

(1958) studied the effect

on fat metabolism of urine collected from healthy people
during periods of fasting.
six hours.

Subjects were fasted for thirty-

From the urine collected during the last twenty-

four hours of this period, a fat-mobilizing material could
be precipitated at pH 5.3 with two volumes of ethanol.
Subsequent separation, and extraction of the material with
dilute sodium carbonate solution resulted in an alkaline
extract which, upon injection into mice, produced an increase
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in liver fat.

Animals receiving the urine extracts from the

same subjects on a normal diet, without fasting, had liver
fat values very similar to those found in saline-injected
animals.
When the dose of fasting urine extract was varied by
Chalmers (1960a) the increase in liver fat was found to be
linearly related to the log dose.

For convenience, the

active material was referred to as Fat Mobilizing Substance
(F.r-·IS)

(Chalmers, 1965) •
Further details of the characteristics of

FMS

were

reported by the same authors and they postulated that FMS
mobilizes fatty acids from adipose tissue by directly augmenting the lipolytic reaction.

FMS activity did not appear

in the urine of fasted hypophysectomized man or goat and
Chalmers et al.

(1960a) concluded that the pituitary (or

adjacent hypothalamus) was necessary for its production.
Comparison of FMS to known lipolytic substances of pituitary
origin reveals important differences and Fl'!S does not appear
to be any of those lipolytic substances (Chalmers, 1965).
Following the extraction of FMS from the urine of
fasting man, Stevenson et al.

(1964) reported the extraction

of a similar material (FMS I) by essentially the same procedure from the urine of fasting rats that also showed fat
mobilizing and hypoglycemic properties in vitro and in vivo.
FMS extracted from the urine of fasting rats caused an
increase in release of free fatty acids from rat epididymal
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fat pads in vitro and upon injection into intact rats produced a weight loss, transient hypoglycemia, hyperlipemia,
and an increase in fatty acid content of the liver.

FMS I

differed from the material isolated by Chalmers et al. in
that a single subcutaneous injection in the rat caused a
transient but pronounced decrease in food intake.
al.

Beaton et

(1964) fractionated FMS I into FMS IA and FMS IB on the

basis of solubility in alkaline and water solutions.

These

two fractions were chemically distinct, the anorexigenic
property of FI-1S I was attributable to the IA component and
the fat mobilizing property to the IB component.

FMS acti-

vity was also detected in the urine of fasting mice, dogs,
sheep, goats and horses

(~ekwick

et al., 1967) but little

information has been reported on the nature of these fatmobilizing materials.
FMS has also been extracted from the urine of fasting
chickens (Nir et al., 1969).

The method used to extract FMS

was essentially that of Chalmers et al.
by Stevenson et al.

(1958) as modified

(1964) and Beaton et al.

(1964).

Dietary Aspects and Application of Stress in Conditions in
which FMS Activity is Found
FMS activity can be detected in human urine after
about 12 hours of fasting (Chalmers, 1965).

Low-calorie

diets also elicit activity provided they contain little
carbohydrate (Chalmers et al., 1960a).

It disappears when

caloric intake is adequate for maintenance, but reappears
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during caloric deprivation (Gordon, 1970).

On normal unre-

stricted diets, or low-calorie high-carbohydrate diets, activity is absent (Chalmers et al., 1960a).

It seems to be

most closely related to carbohydrate intake since dietary
reduction of this specific nutrient will cause FMS to appear
in the urine.

In the human, a critical intake of 80 grams

of carbohydate daily is needed to prevent its appearance
(Gordon, 1970).
However, as noted by Kekwick and Pawan (1967), patients
who have had a pituitary ablation for carcinomatosis and who
have been fasted or deprived of carbohydrates are unable to
produce detectable amounts of FMS in the urine (Chalmers et
al., 1960a).

Chalmers et al.

(1960a) observed no detectable

fat mobilizing or ketogenic activity in the urine in
patients with well-established pituitary deficiency receiving cortisone and thyroid in replacement dosage or in conditions of severe carbohydrate restriction or fasting up to 36
hours.

Kekwick and Pawan (1967) reported that no activity

could be detected in hypophysectomized fasting goats, as in
human subjects with abnormal or absent pituitaries.

An in-

tact pituitary gland appears necessary for the production of
FMS.
The effect of progressive restriction of dietary carbohydrate was studied in an obese patient (Chalmers et al.,
1960a).

Urine was collected on the last two-days of each

four-day dietary period.

Diets provided on thousand cal-

ories of which one hundred were in the form of protein.
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At first, when carbohydrate provided ninety percent of the
remaining calories and fat only ten percent, no ketogenic
activity could be detected in the urine.

Activity began to

appear when the proportion of calories provided by carbohydrate was reduced to half, and it increased progressively
with further carbohydrate restriction.

This relationship

holds true when the diets are given in the reverse order
(Chalmers, 1965).
In very obese patients fasting and low carbohydrate
diets appear to elicit a smaller output of FMS than in nonobese subjects (Chalmers, 1965), presenting the possibility
that a primary defect of its availability plays a part in
the development of obesity.

However, the fasted hypothala-

mic obese rat excretes a greater amount of FMS of increased
specific and total activities than does the control animal,
regardless of whether laboratory chow or a high-fat diet is
fed

and with increased excretion when a high-fat diet is

fed prior to fasting as opposed to a diet composed of high
carbohydrate (Beaton et al., 1966).

Beaton et al.

(1966}

stated that since these animals have increased lipogenesis,
a net increase in body fat, and excrete approximately twice
as much FMS during fasting as do controls, their ability to
produce and excrete a substance for mobilization of fat
appears not to be impaired.

However, adipose tissue taken

from hypothalmic obese rats has a reduced response to FMS
(Beaton et al., 1966a). Beaton et al.

(1966a) noted the gain
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of body fat in these animals may be due to an increased food
·intake and lipogenesis, enhanced by a reduced response of
their adipose tissue to one or more lipolytic agents.
In the absence of dietary restriction no activity has
been detected in late pregnancy, nor after short periods of
exercise (Chalmers et al., 1960a).

A totally adrenalecto-

mized patient found to have a corticotrophin secreting pituitary tumor did not excrete FMS while on an unrestricted
diet but responded normally to carbohydrate deprivation
(Chalmers, 1965).

Chalmers (1965) cited that this observa-

tion supports the view that FMS is not corticotrophin-dependent and shows that functioning adrenal glands are not
required for the production of activity in response to
restriction of carbohydrate intake.
In a number of clinical situations FMS has been detected in the urine when carbohydrate intake was not severely restricted.

Activity has been found in diabetic ketosis,

in widespread malignant disease with wasting, and in the
first few days after surgical operations (Chalmers, 1965),
but in all cases the caloric intake was low (Chalmers et aL,
1960a).

Goth et al.

(1965) confirmed the presence of FMS in

the urine of patients with diabetes.

In contrast, alloxan-

diabetic rats excrete less total activity of FMS than do
control animals (Beaton et al., 1966).

No abnormal activity

was found in a patient with lipodystrophy (Chalmers et al.,
1960a), but in patients with diffuse lipoatrophic diabetes
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consumption of an unrestricted diet failed to suppress urinary activity (Chalmers 1960a; Louis et al., 1960, 1962).
Chalmers (1965) noted that in one of two thyrotoxic patients
activity was present which disappeared during treatment with
carbimazole and therefore could not be attributed to TSH.
Chalmers (1965) detected activity in three out of seven
patients v.rith acromegaly on normal unrestricted diets which
ceased shortly after pituitary implantation in two patients.
FMS levels produced by altering the qualitative composition of isocaloric 1000 kcal diets in obese persons are in
agreement with earlier suggestions by Kekwick and Pawan
(1956 and 1957), that low carbohydrate diets are more effective in producing mobilization and loss of body fat than
isocaloric diets high in carbohydrate (Pawan, 1971).

More-

over, a high-fat low calorie diet produced higher FMS levels
in obese subjects than an isocaloric diet high in protein.
Chalmers et al.

(1960) detected no FHS in the urine of

humans subsisting on a calorically restricted diet composed
largely of carbohydrate.

Beaton et al.

(1965) investigated

the effects of previous diet on the excretion of FMS in the
urine of fasting rats.

Of four diets (high carbohydrate,

high protein, high fat, and high protein-high fat) the
greatest excretion of FMS was observed when the highproteinhigh fat diet was fed ad libitum prior to fasting.

Dietary

protein had no significant effect upon FMS excretion.

Ex-

cretion of FMS was increased by prior feeding of a high fat

9

diet and decreased by feeding of a high-carbohydrate diet.
The greatest total activity excreted per twenty-four hours
was obtained with the diet highest in noncarbohydrate calories.

Kwok (1974) observed the effects of four diets (high

carbohydrate, high fat, noncarbohydrate-high fat, and high
protein) on the excretion of FMS in the urine of rats fasted
for 24 hours at 15°C.

The rats were fed ad libitum 7 days

prior to their fast under cold stress.

Kowk (1974) indicated

that a positive correlation exists between the lipolytic
potency of crude FMS and the proportion of calories from fat
in the diet.
Previous dietary treatment can significantly affect
the response of adipose tissue to FMS (Beaton et al., 1966a).
Previous feeding of a high protein diet or noncarbohydratehigh fat diet inhibits the lipolytic response in vitro of
adipose tissue to FMS.

The release of free fatty acids was

greatest with the high-carbohydrate and high fat diets.

The

release of free fatty acids in the absence of FMS was nonsignificantly different with the tissue obtained from rats
fed the high carbohydrate, high fat, and noncarbohydratehigh fat diets.

Kwok (1974) showed that rats fed a high

carbohydrate diet prior to 72 hours starvation at 0° to 5°C
before sacrifice would provide epididymal fat tissue with
maximum response to FMS.
Karninen et al.

(1962) reported results that suggest

less activity may be excreted by humans in the second day of
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fasting than on the first day.

Chalmers (1965) stated that

this report is in conflict with unpublished data from his
laboratory showing a progressive increase in urinary activity
in two lean subjects given a low-calorie, low-carbohydrate
diet for 5 days.

Pawan's (1971) observations compare favor-

ably with that of Chalmers (1965).

During a 36-hour fast in

normal subjects FMS levels progressively increased with time,
but upon resumption of normal eating, FMS output decreased
and was absent by the eighteenth hour after re-feeding.

Pr~

longing the period.of fasting of obese persons produced an
increase in FMS output from day 1 to day 5 of the fast, but
by day 10 of the fast the FHS levels had again decreased
(Pawan, 1971).

Kekwick and Pawan (1967) observed in five

female obese subjects that upon prolonged starvation FMS
levels were virtually negligible by the fourteenth day.
Crisp et al.

(1968) have observed in subjects with primary

anorexia nervosa of some duration who exhibited considerable
fat loss, that FMS was undetectable in some cases, but on
refeeding these persons,

F~1S

reappeared transiently, for a

few days, and then again disappeared as re-feeding continued
(Pawan, 1971).

Crisp et al.

(1968) and Pawan (1971) stated

that starvation, a povJerful stimulus for

F~1S

production, if

continued without nutrient intake, might cause temporary
exhaustion of the secretory cells.
Beaton et al.

(1966) reported observations on the

duration of fasting on excretion of lipid-nobilizing acti-

ll
vity in the urine of rats.

During fasting at 24°c the great-

est excretion of specific and total activities occurred in
the first twenty-four hours and diminished thereafter up to
seventy-two hours.

Beaton (1966) noted that the sudden

increase of excreted activity may be related to the coincident mobilization of fat in these animals during fasting
and that decreased activity during prolonged fasting could
possibly be due to decreased production or secretion of

F~1S.

The observations by Kwok (1974) compare favorably with those
of Beaton et al.

(1966).

With fasting, there was appreciable

excretion of active FMS, the excreted specific activity being
greatest in the first 24 hour fasting period and diminishing
thereafter.

Kwok (1974) in agreement with Beaton et al.

(1966) stated that the sudden increase of excreted activity
may be related to the coincident mobilization of fat in the
rat during fasting, noting the frequent observation that in
situations in \vhich the mobilization of fat from depots is
known to occur, there is an increased excretion of FMS.
Mobilization of fat during acute exposure to cold
stress is known to occur, presumably in response to the
increased demand for energy.

The urinary excretion of a

fat-mobilizing·substance by rabbits during exposure to cold
has been reported by Braun and Mosinger (1961) .
tions by Beaton et al.

Observa-

(l964a) showed that FMS is not ex-

creted by rats during feeding at an ambient temperature but
is excreted by fed rats during acute exposure to cold of an
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environmental temperature of S°C.

Stevenson et al.

(196S)

observed a progressively increasing excretion of FMS in the
urine of fasting rats with decreasing environmental tempera0

ture from 30° to S

c.

Kwok (1974), upon decreasing the en-

vironmental temperature from 30° to S°C observed a progressive increase in the excretion of crude FMS to a maximum at
1S°C and expressed the opinion that it may well be that increased spontaneous activity (exercise) or shivering is the
causative factor in increased excretion of FMS at about 1S

c.

Exercise has been reported by Basu et al.

0

(1960) to in-

crease serum concentration of free fatty acids, an index of
fat mobilization.
Sex, Age, Metabolic Obesity and Weight Reduction
Pawan (1971) studied the effect of age on the production of FMS in normal persons fasted for 36 hours.

Adult

human subjects, forty years of age produced less FMS than
younger persons.

Levels of FMS decreased with increasing

age above forty years.

Stevenson et al.

(196S) observed

that infant and young children excreted more fat-mobilizing
activity than did young male adults during an 18 or 24 hour
fast.
Beaton (1966) reported observations on the effect of
age and sex on the excretion of FMS.

Young male rats excrete

a greater amount of FMS than do adult rats, the greatest
excreted total activity per 100 gram body weight being at
37 days of age (102 grams).

The amount of FMS excreted did
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not vary appreciably between 37 (102 grams) and 62 (197

gram~

days of age but was decreased between 62 (197 grams) and 78
(297 grams) days.

It is generally accepted that puberty in

the rat is reached between 50 and 70 days.

At the age of

27 days, i.e., prepuberty, male rats fed a high fat diet
excreted more FMS with a higher activity than did female
rats.

However, at 90 days of age (post-puberty), there was

no apparent sex difference in the amount of total activity
of FMS excreted per rat but when expressed per 100 gram body
weight, females excrete more FMS than do males.
Beaton et al.

(1966a) investigated the lipolytic

response of adipose tissue to rat FMS as affected by sex,
age, and location of tissue.

There was no sex difference in

the response of perinephric and omentui!l adipose tissue.

The

response of adipose tissue of a young male rat was considerably less than that of the adult male rat.
Nobody knows the relationship, if any, bet'\veen FHS and
the problem of human obesity.

It is apparent, however, from

even a brief perusal of jts biological effects, that this
lipolytic factor probably arising in, or controlled by, the
pituitary gland, may be part of a physiological homeostatic
control of body mass (Gordon, 1970).

The sensor or detector

and the entire afferent portion of the mechanism have not
been identified, either anatomically or physiologically, but
its potential importance to the problem of weight control
cannot be doubted (Gordon, 1970).
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From observations on very obese patients, fasting and
low carbohydrate diets appear to elicit a smaller output of
FMS than in non-obese subjects (Chalmers, 1965).

He consid-

ered the possibility that a primary defect of this mechanism
plays a part in the development of obesity.

Assuming that

the urinary FMS is a reflection of the production of this
substance in the body and its excretion by the kidneys, the
higher mean urinary FMS levels in the group of non-obese as
compared with the mean values in the obese subjects, together with the observations of Chalmers et al.

(1960) and

Kekwick and Pawan (1968) that injected F.MS causes a mobilization and reduction of the body fat content, suggest that
a relative deficiency of FMS in obese persons may be associated with development of their obesity (Pawan, 1971).

Pawan

(1971) noted that it is of some interest that levels of Fr1S
decrease in individuals with increasing age above forty
years as there is evidence from actuarial studies of a positive correlation between incidence of obesity and age above
forty years, particularly in women.

The high FMS values in

subjects with diffuse lipoatrophy observed by Pawan (1971),
together with the elevated levels in physiological and pathological conditions of increased fat catabolism, support the
hypothesis that FHS may be involved in the regulation of
body fat stores (Pawan, 1971).
Sustained use of FMS induces a fall in body weight in
rats and in humans.

Kekwick and Pawan (1968) placed six
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obese patients on a 1500 calorie diet containing 120 grams
of carbohydrate and gave injections every second day for
varying periods of time, either with saline or with 25-100
milligrams of FMS.

After investigation for a total of 158

patient-days, 80 with saline and 78 with FMS, 61 days of
weight loss and 17 days without weight loss was reported
during the 78 days of FMS injections in contrast to 21 days
of weight loss and 59 days
days of saline injections.

~ithout

weight loss during the 80

Kekwick and Pawan (1963) observ-

ed significant weight losses in mice kept in a metabolic
chamber as a result of admnistering FMS, with

~oss

of weight

being produced in animals even when food intake remained
constant upon presentation of an excess of food to the
animals throughout the experiment.
Repeated administration of FMS into animals for a
period of up to three weeks causes weight loss; control
animals receiving saline or non-fasting urine extract do not
lose weight (Chalmers et al., 1960a).

Loss of weight is not

due to suppression of appetite; the treated animals remain
in good conditions and their food intake does not differ
significantly from that of the controls (Chalmers et al.,
1958, 1960a).

Carcass analysis showed that loss of fat

accounts for more than half the weight loss; the remainder,
water and body protein, is unchanged (Chalmers, 1960a,
1965).
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FMS and Pituitary Hormones
The ability to produce FMS in response to fasting,
carbohydrate deprivation, and other conditions associated
with increased catabolism of fat depends on the integrity
of the adenohypophysis {or adjacent hypothalamus) .

FMS does

not appear during fasting of hypophysectomized animals orof
human subjects with abnormal or absent pituitaries.

There-

fore, an intact pituitary gland appears to be necessary for
the production of FMS.
While the urine of fasting, normal, and sham operated
control animals contained fat-mobilizing activity, no such
activity could be detected in the urine of hypo-physectomized
goats fasting for up to five days {Kekwick et al., 1967}.
Beaton et al.,
rats.

(1964a} demonstrated pituitary-dependence in

Urine extracts from fasting hypophysectomized rats

contained no fat-mobilizing activity in vitro or in vivo.
Chalmers et al.

{1960a) reported seven studies in six

patients with anterior pituitary deficiency.

These included

a patient whose pituitary had been removed for breast carcinoma three weeks before, three cases of chromophobe adenoma, a case of Sheehan's syndrome and a woman in whom the
cause of hypopituitarism was unknown.

All patients were

receiving cortisone and thyroid in replacement dosage.
these patients were subjected to

seve~e

When

carbohydrate re-

striction or fasting for up to thirty-six hours, no fatmobilizing or ketogenic activity was detected in the urine
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by in vitro or in vivo techniques.
Interestingly, FMS has been detected in the urine of
hypophysectomized chickens (Nir et al., 1969).
The relationship of the pituitary gland and its hormones to the fat-mobilizing substance of urine is unclear.
It is not known, whether the pituitary is the origin of FMS
in mammals or if it simply controls the formation and release of FMS else\-Jhere.

However, comparisons of FMS '.vi th

lipolytic substances of knovm pituitary origin reveal important differences.

Although preparations of FMS show weak

melanophore-stimulating and in vitro corticotrophic activity
(Chalmers, 1965) the evidence against the fat-mobilizing
property being due to corticotrophin or MSH appears to be
quite conclusive.

Comparison of a preparation of FMS with

corticotrophin A1 peptide gave widely differing potency
ratios in three assay systems (Chalmers et al., 1960a).
These were (FMS/corticotrophin) :
by rat adrenal in vitro-5/1000;

(1) release of corticoids
(2) release of FFA by rat

epididymal adipose tissue in vitro-25/1000;

(3) increase in

blood ketones in intact, unanesthetized mice-10-100/1.

The

corticotrophin peptide could be inactivated with hydrogen
peroxide and partially reactivated with cysteine; FMS could
be inactivated with hydrogen peroxide but could not be reactivated with cysteine (Chalmers et al., 1960a).

Both

calcium and magnesium ions are required for the lipolytic
effect of corticotrophin in vitro:

FMS requires calcium
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but not magnesium (Chalmers, 1964; Beaton et al., 1965,
1966).

Finally, both corticotrophin and melanocyte-stimu-

lating hormone are lipolytic in the rabbit as well as in the
rat (Raben et al., 1961) but FMS is inactive in leporine
adipose tissue (Chalmers, 1965).

Species differences in the

responsiveness of adipose tissue also differentiate FMS from
the lipolytic peptides isolated from anterior pituitary
glands by Rudman et al.

(1961) and by Friesen et al.

{1962),

since these substances are active in rabbits and guinea pigs
but not in rats or mice.

Administration of commercial cor-

ticotrophin to normal subjects does not lead to the appearance of fat-mobilizing activity in the urine and the urine
of a totally adrenalectomized patient with a corticotrophicsecreting pituitary tumor contained no FMS while on an unrestricted diet but responded normally to carbohydrate
deprivation with excretion of FMS (Chalmers, 1965).

This

observation supports the view that FMS is not corticotrophin-dependent and shows that functioning adrenal glands are
not required for the production of activity in response to
restriction of carbohydrate intake.
The relationship between FMS and growth hormone remains
an unresolved problem.

Chalmers et al.

(1960a) could find

no fat-mobilizing activity in the urine of two hypophysectomized patients after injection of human growth hormone (5mg
intramuscularly) although plasma free fatty acids rose two
to three fold in each case.

The rise in plasma free fatty
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acids produced by growth hormone is slower than that due to
FMS and in vitro, growth hormone shows little or no lipolytic activity (Vaughan and Steinberg, 1963), suggesting that
the adipokinetic effect may belong not to growth hormone
itself but to an agent produced in response to growth hormone or possibly as a metabolite (Chalmers, 1965).
that FMS is such an agent has not yet been obtained.

Evidence
Pre-

parations of FMS do not show growth-promoting activity and
do not cross-react vvi th antisera to human growth hormone
(Chalmers et al., 1960).

Using an assay technique capable

of detecting more than 1 microgram of growth hormone, Professor F. C. Greenwood could find no evidence for growth
hormone in FMS (1 to 100

~g):

It seems safe on these, and

other grounds presented by Chalmers et al.

(1960) and Chal-

mers (1965) to exclude growth hormone as the fat mobilizing
factor in FMS (Pawan, 1971).
In 1964, in the course of improving the method for the
isolation of ACTH from ovine pituitaries, a new peptide was
obtained which differed from all other then known pituitary
hormones and had distinctive properties quite different from
those of ACTH (Li, 1964; Birk and Li, 1964).

Its biological

behavior was tested after it had been characterized chemically.

Upon isolation in pure form and establishment of its

primary structure (Li, 1965), it was designated S-LPH (betalipotropin) by Li because of its lipolytic activity.

Li

suggested the use of the term lipotropin "LPH" to define
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specific fat mobilizing pituitary hormones.

S-LPH has since

been isolated from bovine (Lohmar and Li, 1967), porcine
(Graf and Cseh, 1968; Gilardeau and Chretien, 1970) and
human (Chretien, 1976; Cseh, 1968; and Scott and Lowry,
1974) pituitaries.

Li (1965) isolated S-LPH from sheep

blood.
The complete amino acid sequences of porcine (Graf,
1971) and human (Li, 1976)

S-lipoprotein have beenproposed.

Comparison of the amino acid sequence of human B-lipotropin
with that of the ovine and porcine S-LPH reveals the sequence of the COOH terminal 56 residues to be homologous,
whereas the amino acid sequences at the NH

2

terminusexhibit

considerable variability.
Chretien and Li (1967) isolated in a homogeneous form
another peptide with lipolytic activity calling it Y-LPH.
Sequence of the 58 amino acids forming the Y-LPH molecule
proved to be identical with the 1-58 N-terminal sequence of
S-LPH.

Both Y-LPH and S-LPH contain the entire sequence of

S-MSH representing positions 41-58 of both the LPHs.

Alpha-

MSH has the same amino acid sequence as the 1-13 residues
of ACTH.

ACTH, MSH, and LPH all contain a heptopeptide

common core occurring at positions 4-10 in ACTH and a-MSH
and at 46-52 in the B-MSH related peptides B-LPH and Y-LPH.
All pituitary peptides which contain the heptapeptide core
cause melanophore dispersion in frog skin, stinulate adrenal
steroidogenesis and mobilize lipids from adipose tissue.

It
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has been shown by Sceh and Graf (1971) that the in vitro
activity of the lipotropins, the most specific lipolytic
pituitary peptides, has not surpassed that of ACTH which
exerts other, e.g. steroidogenic potency too.

In equimolar

concentrations, ACTH was more potent than S-LPH, while YLPH was ineffective in inducing lipolysis in rat adipose
tissue.

Human S-LPH, in contrast to human ACTH, is effec-

tive on human adipose tissue (Goth, 1971).
S-LPH is the prohormone for morphine like peptides
(met-enkephalin and endorphins).

In 1975, Hughes reported

the isolation of potent opiate-agonist activity of two pentapeptides called met-enkephalin and leu-enkephalin, corresponding to residues 61-65 in S-lipotropin.

The C-terminal

fragment of S-LPH (61-91) containing this 61-65 sequence of
S-LPH was found to be 20 times more potent as an analgesic
than the enkephalins (Bradbury, 1976).

In 1976, [S-LPH-

(61-91)] was named S-endorphin (Li, 1976).

Besides S-endor-

phin, Lazarus (1976) described the isolation and properties
of a-endorphin [S-LPH-(61-76)]

and a-endorphin [(S-LPH-(61-

77)].
Pelletier (1977) has shown that adrenocorticotrophic
hormone (ACTH) and B-LPH are found in the same storage
granules in corticotrophs and cells of the intermediate lobe
of the pituitary.

Mains (1977) using a mouse pituitary

tumor cell line has shown that ACTH and B-LPH have a common
protein precursor and that ACTH, B-LPH, and B-endorphin are
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stored and then released together.

Yalow and Berson (1971)

believe 'big ACTH' synthesized by the pituitary gland to be
the precursor molecule of both ACTH and LPH.
Anselmino and Hoffman (1931) extracted from the anterior lobe of the pituitary a substance inducing fat mobilization and ketosis, and called it "Fettstoffwechselhormon".
Etzrodt (1978) in studies on the pituitary "Fettstoffwechelhormon" isolated two peptides P-LF II C and P-LF II D from
porcine pituitary glands which display a higher lipolytic
activity than ACTH (Schleyer, Voight and Pfeiffer, 1976).
Complete cross reaction was observed between porcine
l-
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ACTH and P-LF II D.

Etzrodt (1978) concluded that P-LF

.
d eterm1nants
.
I I D h as t h e same 1mmuno
as 1-39 ACTH.
Lelek (1963), Burns (1967), Trygstad (1967, 1968), and
others have isolated fractions with lipolytic activity from
the pituitary and blood.

The characterization of their

chemical and biological activities has not yet been done.
Currently, it is not at all clear whether there exists
a relationship between fat mobilizing substance (FMS) isolated from the urine and many of these lipolytic substances
isolated from the pituitary and blood.
Mode of Lipolytic Action of FMS
On the isolated rat fat pad, FMS produces an increased
rate of release of free fatty acids into the incubation
medium.

This parameter has been utilized as the basis for

the in vitro measurment of FMS lipolytic activity.

Chalmers
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et al.

(1960a) demonstrated that a quantitative dose re-

sponse curve could be obtained.

When the dose of fasting

urine extract was varied the increase in liver fat was found
to be linearly related to the log dose.

FMS is active in

vitro in releasing free fatty acids from rat adipose tissue
at a concentration of less than 1 microgram per milliliter
(Chalmers et al., 1960a), and some preparations of FMS are
active at less than 0.1

~g

per ml (Chalmers, 1965).

These

authors showed that the rate of release is about half that
produced by adrenaline and 40 times that produced by corticotrophin on a weight for weight basis.
In the intact mouse, subcutaneous injection caused a
prompt fall in blood sugar, a rise in blood ketones as well
as an increase in liver fat (Chalmers et al., 1960).
transient hypoglycemia reported by Chalmers et al.

The

(1960a),

lasting for about 2 to 4 hours, which diminishes on repeated injection presumably corresponds with the increased glucose metabolism noted on isolated fat pads (Kekwick et al.,
1967).

The effects onliver fat and blood ketones were max-

imal at six hours and subsided within twelve hours (Chalmers et al., 1960a).

Blood lipids, including total lipids,

phospholipids, cholesterol and free fatty acids also
increased six hours after FMS injection (Chalmers, 1965).
The increase in ketones and free fatty acids in the blood
may last for over 48 hours after a single large injection
(Kekwick et al., 1967).

The effects on liver fat and on the
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circulating levels of lipids and ketone bodies can be considered as the result of an increased rate of entry into
the liver of free fatty acids released from adipose tissue.
The following evidence support this view:

(1) both rats

and mice injected with FMS show a prompt rise in plasma free
fatty acid concentration (Chalmers, 1965);

(2) epididymal

adipose tissue removed from rats previously injected with
FMS release free fatty acids faster than tissue from salineinjected animals (Chalmers, 1965);

(3} addition of FMS to

rat adipose tissue in vitro causes a marked increase in the
rate of release of free fatty acids (Chalmers, 1965).
Kekwick and Pawan (1963) studied the effects of administering FMS to mice kept in a metabolic chamber.

Respira-

tory gas exchange was measured as well as carbon excretion
in stools and urine.

Daily injection caused only a small

rise in oxygen consumption; carbon dioxide output did not
increase and sometimes actually diminished, which was
reflected in a drop in the 24 hour R.Q.
tient).

(respiratory quo-

Carbon balance, however, became markedly negative

due to increased loss of carbon in the urine and, to a
lesser extent, in the stools.

Similar changes were

found after daily injections of FMS for three weeks.

The

form in which the additional carbon is excreted is not
completely clear but it is probably mainly in the form of
ketone bodies representing the disposal of free fatty acids
mobilized in excess of energy requirements.

These results
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appear to exclude the possibility that FMS, besides releasing
free fatty acids into the circulation, may directly augment
their oxidation in peripheral tissues (Chalmers, 1965).
Moreover, FMS has been demonstrated to have no effect on the
utilization of short-chain fatty acids by the isolated perfused rat heart (Chalmers, 1965).
Upon extraction of FMS from the urine of fasting
chickens, injection into chickens caused transient decrease
in food intake and transient increase in plasma free fatty
acids (Nir et al., 1969).

These effects were accompanied

by persisting decrease in plasma triglyceride, cholesterol
and lipid phosphorus.

Slight elevation of blood glucose

occurred but it was not statistically significant.

These

results, so widely different from those obtained with mammals, can only be possible if the process for the metabolism of carbohydrate and fats differ widely in chickens and
mammals.

Some data indicate such a possibility.

Protamine

zinc insulin, for example, causes hyperphagia in mammals
but, conversely, it causes anorexia in chickens (Lepkovsky
et al., 1965).

Moreover, the FMS from the urine of fasting

chickens has.both anorexigenic and fat-mobilizing properties that cannot be separated into two fractions by the
procedure of Beaton et al.

(1964).

Carbohydrate metabolism in rat adipose tissue is
altered in a pattern similar to that of other lipolytic
agents such as epinephrine and corticotrophin (Cahill et
al., 1961).

Cahill et al.

(1961) studied the in vitro
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effect of FMS on glucose metabolism and observed that FMS
increases the incorporation of glucose carbon into glyceride-glycerol in the same manner as does ACTH, epinephrine
and growth hormone (Cahill et al., 1960; Lynn et al., 1960;
and Leboeuf et al., 1961).

These workers suggested that

FMS primarily accelerates lipolysis and does not exert its
action via inhibition of esterification.

The rise in intra-

cellular fatty acids resulting from accelerated lipolysis
induces the following:

(1) increased glucose uptake;

increased glyceride-glycerol synthesis;

(2)

(3) increased meta-

bolism of glucose via the Embden-Meyerhof (glycolytic)
pathway; and (4) increased oxidation by the tricarboxylic
pathway.

Therefore, the action of FMS appears to be at the

cellular level.
It would appear that these in vitro observations support the in vivo situation.

Louis et al.

(1962, 1963) re-

ported that FMS has strong anti-insulin activity in the dog
and suggested that the anti-insulin effect may be due to the
increased fatty acid production.

Randle et al.

(1963) have

shown that glucose uptake by muscle is inhibited by increased availability of free fatty acids for oxidation.
The in vitro relationship between FMS and glucose was
further studied by Beaton et al.

(1966a) who observed that

the in vitro lipolytic response of FMS can be abolished by
addition of glucose to the incubation medium.

It is possi-

ble that glucose aids triglyceride synthesis resulting in
a net decrease in lipolysis.
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In vivo, the hypoglycemic but not the ketonemic effect
of FMS can be abolished in mice by intraperitoneal injection
of glucose at the time of FMS injection (Chalmers).

It has

been shown that the hypoglycemic and fat-mobilizing properties of FMS are not mutually dependent and can be dissociated by ultrafiltration (Beaton et al., l966b).
FMS produces no marked effect on protein metabolism.
Nitrogenous equilibrium is undisturbed by injections of FMS
as compared with periods on identical food intakes and
saline injections (Kekwick et al., 1963).

Repeated injec-

tions of FMS produce a significant diminution of carcass
fat, but little alteration in carcass protein (Kekwick et
al., 1963, 1967).
Mechanism of Action
In opposition to the hypothesis that all lipolytic
agents act by releasing noradrenaline from tissue stores
(Paoletti et al., 1961), observations of Chalmers and Goldiner (unpublished) do not support noradrenaline as an essential mediator of the lipolytic response to FMS:

(l) Most

adrenaline blocking agents when added, in vitro, depress the
lipolytic response to FMS, namely; methalide, dibenzyline,
tolazoline, and dihydroergotamine.

(2) Some inhibitionofthe

lipolytic effect of FMS by dichloroisoproterenol is seen but
is far from complete even at higher

concentration~

Athigher

concentrations the effects of adrenaline and noradrenaline
are completely blocked.

(3) Rat adipose tissue depleted of
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catecholamines by reserpine is fully responsive to FMS.
Now, it is generally accepted that cyclic M1P plays
a key role in hormonal regulation of lipid mobilization
(Vaughan, 1961; Butcher et al., 1965; Robison et al., 197la
and; Kwok, 1974).

Investigation of FMS with labeled isolat-

ed fat cells indicates strongly that cyclic M1P plays an
important role in 11polysis promoted by FMS (Kwok, 1973).
Incubation of isolated fat cells for a brief period of time
with increasing concentration of FMS resulted in increased
cyclic ANP levels without a significant increase in lipolysis.

Longer incubation times demonstrated that lipolysis

occurred and that it occurred after the maximal stimulation
of adenylate cyclase.

A synergistic effect of 1,2 dimethyl-

xanthine and FMS on lipolysis was demonstrated; while
neither 0.25

~~

theophylline nor 25 ugm of

F~S

strongly

stimulated lipolysis, the combination of the two produced a
striking response.

Moreover, FMS is capable of increasing

the intracellular cyclic

k~P

levels in intact isolated fat

cells while inactive FMS (heat-treated FMS, proven to be
inactive) did not increase cyclic
"That cyclic

k~P

&~P

levels (Kwok, 1974).

levels are elevated before lipolysis

is detected in cells treated with

F~S

(Kwok, 1974), is con-

sistent with the suggestion of previous investigators
(Butcher and Sutherland, 1962) that cyclic

~{P

is the cell-

ular mediator of hormone actions and may be related to the
lipolytic cascade proposed by Steinberg (1971).

After FMS
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stimulation of the adenylate cyclase system, cyclic AMP
activates protein kinase which in turn phosphorylates the
hormone sensitive lipase, converting it from an inactive to
a more active form.

In this active form the enzyme controls

the lipolysis of triglyceride to free fatty acids, FFA.
Isolation and Purification of FMS
FMS has been isolated from the urine by a four stage
extraction procedure involving:

benzoic acid precipitation,

sodium carbonate solution or water extraction, alcoholic
precipitation, and lyophilization (Beaton et al., 1964; Kekwick et al., 1967; Kwok, 1974).

Chalmers et al.,

(1960a)

reported that the use of oxycellulose increased the potency
of the isolated product twenty to thirty times while Beaton
et al.

(1966b) reported that Millipore filtration and car-

boxymethylcellulose treatment are without any significant
effect on the activity of the isolated product.
et al.

Both Beaton

(1966b) and Kekwick and Pawan {1967) achieved some

purification of the material by ultrafiltration through
Visking dialysis membranes.

The greater portion of the

activ:ity \vas found in the ultrafiltrate.

Kwok (1974)

achieved some purification of the material by passage
through a Diaflo ultrafiltration apparatus fitted with a PM10 membrane.

Upon further purification of the active PM-10

ultrafiltrate by ultrafiltration with a UM-2 Diaflo membrane,
the activity was found to be associated with the UM-2
residue (retentate).
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When Beaton et al.

(1966b) further fractionated the

active ultrafiltrate, extracted from urine of fasting rats,
through Sephadex G-25 chromatographic column with elution
with distilled water, three active fractions were obtained.
These activities did not appear to be necessarily associated
with protein.

The first active fraction coincided with the

presence of carbohydrate although in small amount.

The

second active fraction coincided with the presence of carbohydrate and some protein.
cided with some protein.

The third active fraction coinConsideration of these observa-

tions immediately raised the question whether rat FMS contains three separate fat-mobilzing substances or whether
there is but one compound attached to or absorbed by different carrier substances.
not yet been secured.

The answer to this question has

In contrast, when the active UM-2

residue (retentate) ultrafiltration product of Kwok (1974)
was fractionated by passage through a Sephadex G-25 column
with elution with distilled water, the activity was found
to be associated only with the first ten 5 ml fractions.
When Kekwick and Pawan (1967) passed their active
ultrafiltrate extracted from the urine of fasting humans
through a column of Sephadex G-50 and then through a column
of Bio-Gel P-10, a reasonably homogeneous extract was
obtained which migrated as a single band when subjected to
electrophoresis on polyacrylamide gel and had one major component peak in the ultracentrifuge with a small subsidiary
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peak.

Kwok (1974) achieved further purification of his

active UM-2 residue ultrafiltration product by column
chromatography with a column of Sephadex G-50 and Bio-Gel
P-10 set in tandem.

When the active eluant peak fraction

was subjected to electrophoresis on cellulose acetate and
polyacrylamide gel, the preparation migrated as a single
protein spot.
Chemical Nature of FMS
Chalmers et al.

(1960a) described the fat-mobilizing

material they had obtained from the urine of fasting humans
as a polypeptide with molecular weight less than 18,000.

It

is not ultrafiltrable and its behavior in dextran gel suspensions suggests a molecular weight below 5,000 (Chalmers,
1965).

It contained about 8% nitrogen and after acid hydro-

lysis, it yielded the following amino acids:

histidine,

phenylalanine, leucine, serine, cystine, aspartic acid and
a trace of alanine (Chalmers et al., 1960a).

It gave a

weak Molisch test for carbohydrate material.

The biological

activity was thermostable up to 80°C in 0.1 N sodium hydroxide.

It was destroyed by boiling for two minutes.

Activity

was completely destroyed by digestion with trypsin and
chymotrypsin but some activity remained after peptic digestion.
Preliminary analysis of rat FMS extract by Stevenson
et al.

(1964) by paper chromatography after acid hydrolysis

indicate that it is a polypeptide composed of histidine,
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phenylalanine, leucine, serine, cystine, aspartic acid and
alanine, with traces of 2 other amino acids.

The extract

obtained from fasted rats contained about 10% nitrogen and
6% carbohydrate.

Unpurified fat-mobilizing substance from

rat urine was reported to contain several amino acids in
addition to those listed by Chalmers et al.:

The nitrogen

contents of human and rat FMS are essentially the same
(Beaton et al., 1964).

Carbohydrate is also present in

crude FMS obtained from rat urine (Beaton et al., 1964).
FMS fractionation on Sephadex G-25 dextran gel by Beaton
et al.

(1966b) suggests a polypeptide molecular weight

between 1,000 and 5,000.

Kwok (1974) fractionated crude

rat FMS into substances greater than 1,000 and less than
10,000 in molecular weight by Diaflo ultrafiltration utilizing respectively, UM-2 and PM-10 Diaflo membranes; he
showed that the active material, as isolated from rat urine,
had a molecular weight between 1,000 and 10,000.

Results

from passage of U!1-2 retentate through Sephadex G-25 columns
suggested that the active material may have a molecular
weight between 5,000 and 10,000 daltons.
Seifter et al.

(1968), after studying the lipid mobil-

izing peptides from various sources, suggested that all
lipid mobilizing peptides reported since 1956 are closely
related chemically.

Many questions concerning FMS cannot

be answered until it can be isolated in pure form.

33
Statement of the Problem
Production of FMS has been measured in vivo by using
the ability of the urinary extracts to (1) raise blood ketones,

(2) raise free fatty acids levels in the blood of

intact mice, and (3) diminish mouse carcass fat.

Produc-

tion has been measured in vitro by the ability of FMS to
release free fatty acids from the in vitro fat pad.

During

lipolysis both free fatty acids and glycerol are released.
The fatty acids can be activated and reesterified.

Glyce-

rol, however, is not metabolized to any significant extent.
There exists the inherent danger of relying on only one
criterion for measuring in vitro FMS lipolytic activity.
To date, no in vitro bioassay utilizing glycerol has been
employed in a quantitative comparison to free fatty acid
release as an index of in vitro FMS lipolytic activity.

It

has become increasingly evident that differences in adipose
tissue due to the number of adipose tissue cells and the
size of these adipocytes can have an effect upon the metabolic activity of the adipose tissue fat pad.

Accordingly,

attention need be directed to modification of assay procedures to express the lipolytic activity of FMS as a function
of cell size and number.
The precise chemical nature of FMS remains elusive, and
none of its physical characteristics have been reported.
Progress has been hampered by the lack of highly purified
preparations in sufficient quantity for basic studies.
Application of the technique of iso-electric focusing to
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this biologically active material may prove to be a powerful tool for future analytical and/or preparative separation
of FMS.

Physicochemical information can be obtained from

isoelectric data to contribute towards characterization of
FMS in terms of its physical properties.
Obesity and age have been shown to affect the urinary
excretion of FMS.

Hence body weight probably has an effect

on the quantity and quality of its excretion and should be
studied in more detail.
The purpose of this thesis is to obtain further
information relevant to the characterization of this lipolytic factor.

Attention will be directed to the following

parameters:

(1) to improve the efficiency of purification

of the active principle;

(2) to investigate the influence

of weight and age factors on its urinary excretion; and (3)
to establish an assay system more specific for target cellFMS interaction than has been used previously, and based
upon the release of glycerol and of fatty acid from fat
cells of known size and lipid content.

CHAPTER II
MATERIALS AND METHODS
General Experimental Procedures
The first objective at the start of this work was to
obtain a sufficient quantity of FMS for basic studies.
Male albino rats of the Sprague-Dawley strain were placed
on a high fat diet for a 7 day period.

On the 7th day, the

animals were placed in a cold room at 15°C and their urine
was collected during a 24 hr fast.
Crude FMS was extracted from the urine by a four stage
process:

(1) benzoic acid precipitation of FMS from freshly

passed urine at pH 5.3;

(2) extraction of FMS from the pre-

cipitate with distilled water;

(3) alcoholic precipitation

at pH 5.3; and (4) lyophilization of the precipitate after
redissolving in distilled water.

Crude, FMS was then bio-

assayed in vitro for lipolytic activity.
The influence of weight, and hence age factors, on FMS
bulk urinary excretion and activity were studied.

Eleven

groups of rats, 30 in each group and varying in mean group
weight, were subjected to the above stated routine.

The

urine collected from the rats within a group was pooled,
and the FMS extracted, weighed and bioassayed in vitro for
lipolytic activity.
Three different assay procedures were used to test the
lipolytic activity of FMS.

Being a relatively rapid and
35
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accurate method, the lipolytic activity of FMS was assayed
in vitro, at each stage of purification, by its ability to
increase the release of free fatty acids (FFA) from epididymal fat pads of the rat in a medium of Krebs-Ringer phosphate buffer (pH 7.4) containing 4% bovine serum albumin.
The quantitative release of FFA into the medium was determined by the method of Duncombe (1964) as modified and used
by Kwok (1974).

In this assay, chloroform-soluble copper

soaps of the FFA are formed and the chloroform-soluble
copper is converted to a colored complex by reaction with
1,5 diphenylcarbohydrazide.
To improve the sensitivity of this biological assay
an experimental procedure was set up to assay the increased
release of free fatty acids via direct FMS-fat cell interaction.

Fat cell suspensions were used for this purpose

and were prepared according to the method of Rodbell (1964).
To remove the inherent problem of relying on only one
criterion for measuring in vitro FMS lipolytic activity, a
third assay, was established. In this case, increased glycerol release from direct FMS-target cell interaction was
quantitatively measured as an index of in vitro FMS lipolytic activity.
Glycerol release was determined by modification of the
sensitive enzymatic method of Davidson and Karjala (1970).
An Aminco-Bowman spectrophotofluorometer was used with
excitation set at 350 nm and emission at 455 nm to measure

NADH

2
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which is formed when glycerol is oxidized by glycerol

dehydrogenase.
Data obtained in FMS-target cell interaction assays
were expressed in two v1ays.

In the first approach, total

lipid was extracted from the fat cells used in the assay
system, by the biphasic system established by Felch et al.
(1957) mixing chloroform, methanol and a known aliquot of
cell suspension; the glycerol and/or free fatty acid release was expressed on a per unit cell lipid basis.
The second mode of data expression provided an opportunity to study FMS lipolytic activity as a function of
cell size and number.

Increasing evidence shows that cell-

ularity of the adipose tissue can affect the metabolic
activity of this tissue, and can provide an inaccurate
amount of reported activity per target cell if expressed
on a per unit wet weight of tissue basis.

FFA release was

expressed per 10 6 target cells, using rats weighing 130150 grams.
Adipose tissue cellularity was determined on every cell
suspension prepared for bioassay by use of the Coulter
Electronic Counter, which gave cell number, as well as the
means of obtaining the diameter and volume of the target
cells used.
The general approach and techniques of subjecting
crude FMS to partial purification by ultrafiltration with
PM-10 and UM-2 Diaflo membranes, and then further fraction-
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ation by passage through Sephadex G-50 and Bio-Gel P-10
chromatographic columns, were similar to those which have
been used previously by Kwok (1974) in our laboratory but
with some modifications.
In the ultrafiltration studies the usefulness of the
substitution of a DM-5 Diaflo membrane, for the UM-2 membrane or of its incorporation into the existing purification protocol along with the PM-10 and UM-2 membranes was
investigated.
Column chromatography was applied to the active fractions obtained from each of these modes of ultrafiltration.
Both Sephadex G-50 and Bio-Gel P-10 columns in tandem and
Bio-Gel P-10 columns alone were used in the further purification of FMS.
Highly purified FMS preparations were subjected to
isoelectric focusing.

The effluent was monitored with an

LKB Absorptionmeter at 280 nm and fractions representing
elution peaks were pooled, dialyzed, lyophilized, and bioassayed in vitro for lipolytic activity.
The active variants of FHS were examined for homogeneity, amide gel electrophoresis and densitometry of
the destained gel columns.

39
Chemicals
Acrylamide, Eastman Organic Chemicals,

~o.

5521

Albumin, Bovine, Fraction V Powder, Sigma Chemical Company,
No. A4378
Albumin, Dried Human Protein Standard, Dade (Div. of

.~er-

ican Hospital Supply Corp., No. PR5-411
Alcohol, 95%, Commercial Solvents Corporation
Alcohol, absolute, Commercial Solvents Corporation
Ammonium Persulfate, Mallinckrodt Chemical Works, AR, No.
3460
Ampholine Carrier Ampholytes, pH range 3-10, LKB Instruments Inc., Rockville, Maryland
Benzoic Acid, Aldrich Chemical Company, No. 10,947-9
Bio-Gel P-10, 50-100 mesh, Bio-Rad Laboratories, No. 81102
BIS (N,N'-Methylene-bisacrylamide), Eastman Organic Chemicals, No. P 8383
Bromphenol Blue (Water Soluble), Hartman-Leddon Company,
No. 859
Calcium Chloride, Anhydrous, Mallinckrodt Chemical Works,
AR, No. 4132
Casein, Nutritional Biochemicals Corporation
Chloroform, Hallinckrodt Chemical Works, AR, No. 4440
Collagenase, Type III, Fraction A, Sigma Chemical Company,
No. C-0255
Coomassie Brilliant Blue R-250, Colab Laboratories, Inc.,
No. ll-152B
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copper Sulfate • 5H 0, Mallinckrodt Chemical lvorks, AR, No.
2
4844
Crisco, Proctor and Gamble Company
Cupric Nitrate·3H 2 0, Fisher Scientific Company, No. 771342
1,5 viphenylcarbohydrazide, Eastman Kodak Company, No. 618
Fiber, Non-nutritive, Nutritional Biochemicals Corp.
Glycerol, Reagent Grade, Fisher Scientific Co., No. G33
Glycerol Dehydrogenase, Grade I, Sigma Chemical Co., No.
50C-6860-l
Glycine (Ammonia Free), Eastman Organic Chemicals, No. 445
Hydrochloric Acid, J. T. Baker Chemical Co., No. 9535
Isopropyl Alcohol, Mallinckrodt Chemical Works, AR, No.
3032
Kodak Photo-Flo
Liver Powder, Nutritional Biochemicals Corporation
Magnesium Sulfate·7H 2 0, Mallinckrodt Chemical Works, AR,
No. 6056
Methanol, Anhydrous, Mallinckrodt Chemical Works, AR,
No. 3004
B-Nicotinamide-adenine dinucleotide, Grade III, Sigma
Chemical Co., No. D 5755
Palmitic Acid, Sigma Chemical Company, No. P-0500
Perchloric Acid, Mallinckrodt Chemical Works, AR, No. 2766
Phenol Reagent, Folin and Ciocalteu, Harleco Co.
Phosphoric Acid, Hallinckrodt Chemical Works, AR, No. 2796
Potassium Chloride, Granular, Mallinckrodt Chemical Works,
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AR, No. 6858
Potassium Ferricyanide, Sargent-Welch Scientific Co., AR,
No. 14180
Potassium Hydroxide, !1atheson, Coleman and Bell, No. CB
1158
Riboflavin, Eastman Organic Chemicals, No. 5181
Salt l\iixture, Wesson Modified Osborne-Mendel, General Biochemicals, No. 170900
Sephadex G-50, Medium, Pharmacia Fine Chemicals Inc.
Siliclad, Clay Adams Company
Sodiurn Carbonate, Anhydrous, Mallinckrodt Chemical Works,
AR, No. 7521
Sodium Chloride, Mallinckrodt Chemical

~\forks,

AR, No. 7 581

Sodium Dodecyl Sulfate (SDS), Bio-Rad Laboratories, No. C161-0300
Sodium Hydroxide, Pellets, Mallinckrodt Chemical Works, AR,
No. 7708
Sodium Phosphate Dibasic, Anhydrous, Mallinckrodt Chemical
Works, AR, No. 7917
Sodium Tartrate, Mallinckrodt Chemical Works, AR, No. 2386
Sucrose, Nutritional Biochemicals Corporation
Sulfuric Acid, Mallinckrodt Chemical Works, AR, No. 2876
TEMED (N,N,N',N'-Tetramethylethylenediamine), Eastman
Organic Chemicals, No. 8178
Thymol, Aldrich Chemical Company, No. 11,209-7
Toluene, Mallinckrodt Chemical Works, AR, No. 8608
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Trichloroacetic Acid I Hallinckrodt Chemical rvorks I AR,
No. 2928
Triethanolamine, Eastman Organic Chemicals, No. 1599
'I'RIZlvlA-BASE, Sigma Chemical Company, No. T 1503
TRIZHA-HCl, Sigma Chemical Company, No. T 3253
Trypsin, Type III, from Bovine Pancreas, Sigma Chemical
Company, No. T-8253
Trypsin Inhibitor, Type II-0, from Ovomucoid (Egg White),
Sigma Chemical Company, No. T-9253
Vitamin Diet Fortification

~1ixture,

Nutritional Biochemi-

cals Corporation
Urine Collection and Extraction of Crude FMS
In all experiments, both for the collection of urinary
FMS and for its bioassay in vitro, white male, albino rats
of the Sprague-Dawley strain purchased from Locke-Erickson
Laboratories, Maywood, Illinois were used.

For the collec-

tion experiments, groups of 30 rats were immediately housed
upon arrival into individual screen-bottomed cages at an
environmental temperature of 25 + 1°C and fed laboratory
chow ad libitum for the next 7 days.
Following this period they were placed on a high fat
diet for the following 7 days.
fat diet is given in Table 1.

The composition of the high
The diet provided 84.7% of

of the Calories as fat, 9.4% as protein and 5.9% as carbohydrate with an average of 5.22 Calories per gram.

The

high fat diet was prepared every two days and was provided
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TABLE 1
CONSTITUENTS AND CALORIC CONTENT OF THE
HIGH FAT DIET*

Constituent

Percent by
Weight

Casein

Calories/
Gram

13

0.49

8

0.31

Crisco

50

4.42

Non-Nutritive
Fiber

24

Sucrose

Salt Hixture

3

Liver Powder

2

Total

100

* Plus 2% vitamins.

5.22

daily to the animals.
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Fresh drinking water was available

ad libitum.
On the seventh day of this regimen, the animals were
weighed and transferred to individual stainless steel metabolism cages, fitted with urine-feces separators, in the
cold room at 15°C.

The animals were then fasted for the

next 24 hours, during which time urine was collected and
pooled.

The urine was collected in 125 ml Erlenmeyer

flasks containing 5.0 mls of 10% thymol in isopropanol as
a preservative.

The preservative was not used however if

the urine was to be processed immediately after its collection and this was generally the case.
Following their 24 hour fast under cold stress, the
rats were refed laboratory chow ad libitum at room temperature for the next 7 days before being placed back on the
high fat diet and subsequently, the 24 hour fasting period
and the cycle repeated.

The experimental cycle was repeat-

ed for purposes of urine collection until the rats had
reached weights over a group mean of 450 grams.
Crude FMS was extracted from the urine according to
the method of Beaton et al.

(1964).

The pH of the pooled

24 hour urine collection from groups of 30 rats was pH
adjusted to 5.3 with 1.0 N HCl.

One volume of saturated

benzoic acid solution in 100% ethanol was added for each
10 volumes of urine with constant stirring.
was mixed thoroughly for at least 15 minutes.

The slurry
Precipita-
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tion was allowed to proceed overnight at 4°C in a stoppered container.

The bulky precipitate which formed served

to adsorb and coprecipitate

F~S

from the urine.

The con-

tents were transferred to 100 ml Corning centrifuge tubes.
The precipitate was centrifuged at 5,000 x g at 0

0

to 5

0

c,

in an International Centrifuge, Model PR-2 {840a head),
for 30 minutes.

The supernatant was discarded.

In order to remove the benzoic acid, the precipitate
was washed in the large centrifuge tubes with cold 95%
ethanol at pH 5.3.

A glass rod was used to break up any

lumps and to mix the contents thoroughly.

The aqueous

solution was then centrifuged at 5,000 x g at 0° to 5°C for
30 minutes.

The ethanolic washings were discarded on each

occasion after centrifugation.

The precipitatewaswashed

twice.
FMS was then eluted from the precipitate by adding
100 ml of distilled water and mixing thoroughly over a
period of about 15 minutes using a glass rod to break up
any lumps.

The aqueous solution was then centrifuged as

before and the supernatant retained.
Reprecipitation of FMS was carried out by adjusting
the pE of the aqueous solution to pH 5.3 with 1.0

~

HCl or

1.0 N NaOH as required, and slowly adding 2 volumes of cold
absolute alcohol while stirring constantly with a magnetic
stirrer.
The suspension was put in the cold room at 4°c for the
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next 24 hours in a stoppered container for precipitation to
be completed.

The suspension was then transferred to 100

ml Corning centrifuge tubes, and centrifuged at 5000 x g at
0° to 5°C in the International Centrifuge, Model PR-2, for
30 minutes.

The supernatant was discarded.

To the residue 50 ml of distilled water was added and
the slurry mixed thoroughly and left for 15 minutes to dissolve the FMS.

After centrifugation for 30 minutes at 0°

0

to 5 C at 5000 x g, the supernatant was collected and lyophilized.

The lyophilized product, crude Fr1S, was stored

in the refrigerator in a tightly stoppered container.
Free Fatty Acid Determination
The lipolytic activity of FMS was assayed in vitro by
incubation with epididymal fat pads from male rats in a
medium of Krebs-Ringer phosphate buffer (pH 7.4) containing
4% bovine serum albumin.

The colorimetric method developed

by Duncombe (1964), as modified by Kwok (1974), was used
for the quantitative determination of free fatty acids (FFA)
released into the incubation medium.

In this assay, chloro-

form soluble copper soaps of the FFA are formed and the
chloroform soluble copper is converted to a colored complex
by treatment with 1,5 diphenylcarbohydrazide.
Reagents
1 M Triethanolamine:

14.9 gms of triethanolamine was dis-
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solved in deionized water and diluted to 100.0 ml with
deionized water.

6.45% Cu(No ) -3H o:
6.45 gms of cupric nitrate trihydrate
3 2
2
was dissolved in deionized water and diluted to 100.0 ml
with deionized water.
Copper reagent:

A mixture of equal volumes of 1 M tri-

ethanolamine and 6.45% cupric nitrate trihydrate solution
was prepared when needed.
1,5 Diphenylcarbohydrazide Solution:

0.5 gm of 1,5 di-

phenylcarbohydrazide was dissolved in absolute methyl
alcohol and diluted to 100.0 ml with absolute methyl alcohol.

This solution was prepared just prior to use, as

aging of this reagent results in increased blank values.
Standard Fatty Acid Solutions:

Six standard solutions of

palmitic acid ranging from 20 ill1 to 120 uM in chloroform
were prepared namely:

20

w~,

40

~,

60

~1,

80 uM, 100

u~,

and 120 uM.
Krebs-Ringer Phosphate Buffer (pH 7.4) Containing 4% Albumin:

Krebs-Ringer phosphate buffer containing the

following components was prepared:

NaCl, 128 mM; Mgso ,
4

1.4

and Na HP0 , 10 W-1.
2
4

~~;

CaC1 , 1.4
2

~;

KCl, 5.2

~;

The phosphate buffer was made up fresh daily and the pH
adjusted to 7.4 after addition of sufficient bovine
serum albQmin to yield a 4% (w/v) solution.
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Preparation of Standard Curve
5.0 ml of each of the standard palmitic acid solutions
were placed in glass-stoppered 17 x 135 mm (12 ml) Pyrex
centrifuge tubes.

In addition, 5.0 ml of chloroform

was pipetted into an identical glass-stoppered centrifuge
tube to serve as the blank.

2.5 ml of copper reagent was

then added to each tube and the solutions were mixed
thoroughly with a Vortex mixer set at top speed for 30
seconds.
The resulting two layers were allowed to separate
and approximately 4 ml of the chloroform layer was removed
with a 6", 18 gauge needle and syringe, and transferred to
another 17 x 135 mm glass-stoppered Pyrex centrifuge tube.
Extreme care was taken not to transfer any of the copper
solution.

About 2 ml of deionized water was added to the

top of the chloroform layer in each of the tubes without
any mixing of the two layers.

The tubes were centrifuged

in an IEC Clinical Centrifuge (809 head) set at speed #6
for 10 minutes.
The aqueous layer was completely removed along with
a small amount of chloroform layer with a glass disposable
pipet therefore, insuring that any small amount of the
copper reagent remaining in the chloroform layer was removed.
Aliquots of 1.0 ml of the chloroform solution of the
soap were pipetted into 5.0 rnl volumetric flasks.

1.0 ml

of the 1,5 diphenylcarbohydrazide solution was added to
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each flask, and the mixture was diluted to volume with
chloroform.
The absorbance of each solution at 540 nm was read
in a Beckman DU Spectrophotometer exactly 5 minutes after
the addition of the complexing agent.
standard curve appear in Table 2.

The data for this

A linear relationship

between the absorbance at 540 nm and the concentration of
palmitic acid over the range of 4 uM to 24 W.1 is shown in
Figure 1.
Determination of Biological Activity of FMS Based on FFA
Release from Epididymal Fat Pads
An epididymal fat pad weighing 250 mgs, removed from
130-150 gm male rats was placed in a 25 ml Erlenmeyer flask
containing 4 ml of Krebs-Ringer phosphate buffer containing
4% albumin.

After the addition of 100 ug of FMS (or test

material) in 1.0 ml of the Krebs-Ringer phosphate buffer,
the flask contents were incubated for 3 hours at 37°C in a
Dubnoff Metabolic Shaker using air as the gas phase.
At the end of the incubation, 1.0 ml of the incubation mixture was diluted with 1.0 ml of distilled water and
extracted in a 18 x 150 mm glass-stoppered centrifuge tube
with 5.0 ml of chloroform by mixing for 1 minute
tex mixer set at top speed.

The mixture was centrifuged in

an IEC Clinical Centrifuge (setting 6:
minutes.

on a Vor-

809 head) for 20

The aqueous and chloroform layers were separated

by a disc of precipitated protein.

3.0 ml of the chloro-
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TABLE 2
Standard Curve Data for Determination of
Free Fatty Acids
Palmitic Acid
uM

No. of
Determinations

Absorbance*
540 nm

4

12

0.061 +
- 0.021

8

12

0.161 + 0.018
-

12

12

0.258 + 0.021
-

16

12

0.382 -+ 0.016

20

12

0.493 -+ 0.021

24

12

0.614 +
0.013
-

* Mean + standard deviation
-
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Figure 1.

Standard Curve for the Determination of
Free Fatty Acids.

5.2
form solution were pipetted into a clean dry tube and analyzed for free fatty acids.

The concentration of the FFA

in the circulation medium was calculated from the regression line equation of absorbance versus concentration determined by the method of least squares, namely F

+ 2.18, where F represents the
A, the absorbance value.

ru~

=

36.01A

concentration of FFA and

The total FFA released to the

medium as umoles was calculated by multiplying the value of
F by the dilution factor.
Preparation of Isolated Fat Cells
Isolated fat cells were used in place of intact epididymal fat pads in an attempt to improve the existing assay
used for free fatty acid release by the removal of the heterogeneous cell population that exists in fat pads (Butcher and Baird, 1968), and to increase the sensitivity of the
fat cells to FMS through the increased sensitivity attributed to fat cells when assayed in their isolated form to lipolytic agents (Fain et al., 1972).
Fat cells were isolated according to the procedure of
Rodbell (1964), as modified by Moskowitz and Fain (1970),
and applied by Kwok (1974) in his investigation of FMS elevation of cM11P levels with labeled adipocytes.
White male albino rats weighing not more than 100 gms
were purchased from Locke Erickson Laboratories in Maywood,
Illinois.

The rats were maintained on laboratory chow ad

libitum until they weighed 130-150 gms, upon which, they
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were killed by decapitation.

It has become increasingly

evident that differences in adipose tissue mass, due to
the number of adipose cells in the tissue and their respective size, can have an effect on the metabolic activity of
this tissue.

Therefore, all preparations were made from

rats weighing between 130-150 grams.

The mean diameter of

fat cells obtained from rats in this weight range is approximately 45 urn, in contrast to a mean diameter of approximately 78 urn in rats weighing 400 to 450 grams.

Small cells

were used rather than the large cells since it has been
demonstrated that large adipocytes from adult rats were less
sensitive to glucagon stimulation of lipolysis than small
cells from young animals (Manganiello and Vaughan, 1972;
Livingston et al., 1974).
Immediately after decapitation, the epididymal fat
pads were removed quickly and rinsed in 0.9% NaCl.

Poly-

ethylene centrifuge tubes and siliconized glass vessels
were used during the preparation and incubation of the fat
cells.

Up to 10 grams of pooled rat epididymal fat pads

were added to a siliconized 25 ml flask containing 10 ml of
Krebs-Ringer phosphate buffer, pH 7.4, with 4% (w/v) bovine
serum albumin.

10 mgs of collagenase and 4.0 mgs of cry-

stalline trypsin were added to each 25 ml siliconized Erlenmeyer flask.

Cells were isolated by digestion with

trypsin in addition to collagenase in order to diminish the
effects of insulin and insulin-like substances on the re-
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sponse to lipolytic agents.

No glucose was present during

isolation or the incubation of the cells.

When the in

vitro relationship between FMS and glucose was studied by
Beaton et al.

(1966a), it was observed that the in vitro

lipolytic response of FMS was abolished by addition of glucose to the incubation medium.
The mixture was incubated at 37°C for 1 hour in a
Dubnoff Metabolic Shaker.

The whole digest was then trans-

£erred to a polyethylene centrifuge tube containing 20 ml
of Krebs-Ringer buffer warmed to 37°c.
Fat cells were liberated from the tissue fragments by
gentle stirring with a siliconized glass rod.

Liberation

of the fat cells was manifested by an increased turbidity
of the medium.

Fragments of tissue still remaining after

this treatment were removed with forceps.
The suspended cells were then centrifuged in polyethylene centrifuge tubes for 1 minute at 400 x g.

The fat

cells floated to the surface and the stromal vascular cells
sedimented.
piration.

The stromal-vascular cells were removed by asAfter gentle stirring of the cell suspension,

fat droplets which formed from the breakage of some of the
fat cells, floated more rapidly to the surface than the fat
cells.
face.

These fat droplets were aspirated off from the surThe adipocytes were then washed by suspending them

in 10 ml of warm Krebs-Ringer phosphate buffer and centrifuging for 1 minute at 400 x g; any remaining stromal vas-
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cular cells were aspirated off after centrifugation.

Any

remaining fat droplets were aspirated off the surface after
gentle stirring.

The washing procedure was repeated three

times in order to insure complete removal of the stromal
vascular cells.

The adipocytes were finally suspended in

20 to 25 ml of Krebs-Ringer phosphate buffer containing
0.1 mg per ml of trypsin inhibitor.

The cell suspension

was swirled to ensure delivery of uniform suspension of
cells immediately prior to use.
Determination of the Biological Activity of FMS Based on
FFA Release from Epididymal Fat Cells
The lipolytic activity of FMS was measured in vitro
on the basis of the increased release of free fatty acids
from isolated fat cells in a medium of Krebs-Ringer phosphate buffer (pH 7.4) containing 4% bovine serum albumin.
The colorimetric method developed by Duncombe (1964) as
modified by Kwok (1974) was used, as it was applied to the
in vitro bioassay using epididymal fat pads, for the quantitative determination of free fatty acids released into
the medium.
2.0 ml of fat cell suspension was placed in a 25 ml
Erlenmeyer flask containing 2.0 ml of Krebs-Ringer phosphate
buffer with 4% albumin.
100 ug of

F~1S

After the addition to the flask of

(or test material) contained in 1.0 ml of the

Krebs-Ringer phosphate buffer, incubation was allowed to
proceed for 3 hours at 37°C in a Dubnoff ~etabolic Shaker
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using air as the gas phase.
At the end of incubation, the incubation mixture was
very carefully transferred to polyethylene centrifuge tubes.
Fat cells were separated from the aqueous incubation mixture
by rapid centrifugation for 1 minute in an IEC Clinical
Centrifuge (speed setting 6:

809 head) for 20 minutes.

The

adipocyte layer was removed by aspiration.
1.0 ml of the remaining incubation mixture was placed
into a 17 x 135 mm glass-stoppered Corning centrifuge tube
containing 1.0 ml of distilled water and extracted with 5.0
ml of chloroform by mixing for 1 minute on a Vortex mixer
set at top speed.

The mixture was then centrifuged as before

in the clinical centrifuge for 20 minutes.

3.0 ml of the

chloroform solution were pipetted into a clean dry tube and
analyzed for free fatty acids as described previously.

The

total FFA released to the medium as umoles was calculated by
multiplying the value of F by the dilution factor and then
dividing by 1000.
The total FFA released to the medium was expressed as
umoles of free fatty acids released by 100 ug of FMS (or test
material) acting on rat epididymal adipose tissue fat cell
0

suspension equivalent to 1 gram of lipid for 3 hours at 37 C,
and as umoles of free fatty acids released per 10

6

epididymal

fat cells being acted upon by 100 ug of FMS (or test material) for 3 hours at 37°c.
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Extraction of Total Lipid from Fat Cell Suspensions
The lipid concentration of the adipose tissue cell
suspension was measured by the method developed by Folch et
al.

(1957).

Reagents
Chloroform-Methanol Mixture:
0.05% (w/v) Aqueous cacl 2 :

2:1 (w/v).
50 mg of cac1 2 was dissolved in-

to distilled water and diluted to 100.0 ml with distilled
water.
Pure Solvent Upper Phase:

Prepared by mixing at 3.0 ml ali-

quot of chloroform with 48.0 ml of methanol and 47.0 ml of
0.05% CaC1 •
2
Procedure
8.0 ml of chloroform and 4.0 ml of methanol were placed in a separatory funnel.

2.0 ml of cell suspension in

Krebs-Ringer phosphate buffer, pH 7.4, with 4% bovine albumin was added.

The contents of the separatory funnel were

shaken vigorously for approximately 30 minutes.

Upon stand-

ing, a biphasic system was obtained, which contained no
interfacial fluff.

The volumes of the upper and lower phase

were respectively, 40 and 60 per cent of the total volume
of the system.
substances.

The upper phase containing the non-lipid

The lower phase containing essentially all the

lipids.
This biphasic system was allowed to stand for 4 hours.
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Afterwards, as much of the upper phase as possible was removed by siphoning, and removal of its solutes was completed by rinsing the interphase three times with pure solvent
upper phase mixture that contained 0.05% (w/v) Cacl
place of water.

2

in

In rinsing, 2.0 ml of pure solvent upper

phase mixture was allowed to flow gently from a pipette
onto the walls of the separatory funnel.

The washing fluid

collected on top of the lower phase without any mixing of
the two phases.

After the separatory funnel was rotated

gently, the upper phase mixture was removed by siphoning.
The lower phase was emptied from the separatory funnel into a tared beaker.

Following overnight evaporation

the difference in weight represented the total lipid per
2.0 ml cell suspension.
Determination of Adipose Cell Size and Number
In exploring the direct lipolytic effect of FMS on
epididymal fat tissue consideration should be given to the
cellularity of the chosen fat pads in terms of their cell
size and number.

It has become increasingly evident that

differences in adipose tissue mass due to the number of
adipose cells in the tissue and the size of these adipocytes
can have an effect on the metabolic activity of this tissue.
It has been demonstrated that large adipocytesexhibfr
a marked resistance to the lipolytic action of glucagon v1hen
compared to small cells (r1anganiello et al., 1972; Living-
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ston et al., 1974).

In vitro studies utilizing rat adi-

pose tissue or isolated fat cells have indicated that fat
tissue from older animals is less sensitive to catecholamines than fat tissue from younger animals.

These observa-

tions connected with the knowledge that fat cell size in
the rat increases throughout growth, has led to the concept that fat cells may lose their sensitivity to the lipolytic effects of catecholamines as they enlarge.

Extending

this concept to the obese individual who has fat cells of
increased size projects the expectation of finding the same
apparent metabolic deficit (Hartman et al., 1971).
Hartman et al.

(1971) demonstrated that when lipolysis

is based on the amount of triglyceride in the incubation
medium or on tissue weight, as is the usual custom, or on
the cell surface area, lipolysis inversely relates to cell
size.

But when norepenephrine stimulated lipolysis was

expressed per 10

6

cells lipolysis was independent of cell

size.
Experimental findings such as those noted above indicate that the lipolytic action of FMS on adipose tissue may
vary when using the tissue from rats differing in body
weight and/or subjected to different experimental treatment
if tissue cellularity is not taken into consideration.
Therefore, a method based on cellularity may prevent misleading information about the metabolic potential of FMS on
its target tissue.
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Various methods for determining adipose tissue cellularity include the following:

(1) microscopic examination

of isolated fat cells in the unfixed state with the aid of
an ocular micrometer,

(2) DNA content which produces a

nuclear, and hence cellular tally, and (3) electronic
counting.

The first method is tedious since it involves

the measurment and counting of large numbers of cells which
have the appearance of irregular polygons in various orientations to the cut plane.

The measurement of DNA in the

intact tissue is an inexact estimate of adipose cellularity,
since blood vessels, fibrous tissue, mast cells, etc., contribute unknown amounts of DNA to the total.

A determina-

tion of the DNA content of adipose cell suspensions may not
be a valid estimate due to the cell breakage caused by
collagenase treatment.

As a result, the Coulter Electronic

Counter, Model B (Coulter Electronics, Inc., Hialeah, Florida) was used to count and size the epididymal fat cells,
because of its simplicity, accuracy and general applicability.
Coulter Counter Principle
Particles or cells, suspended in an electrolyte can be
sized and counted by passing them through an aperture with
a specific path of current flow for a given length of time.
As particles or cells pass through the aperture and
displace an equal volume of electrolyte, the resistance in
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the path of current changes.

This results in corresponding

current and voltage changes.

The quantity (magnitude) of

this change is directly proportional to the volumetric size
of the particle or cell.

The number of changes within a

specific length of time is proportional to the number of
particles or cells within the suspension.
Preparation of Adipocytes
Albino male rats of the Sprague Dawley strain (body
weight range, 130-150 gms) were stunned by a sharp blow to
the head and decapitated and the fat cells were isolated
from epididymal fat pads after exposure to collagenase
according to the method of Rodbell (1964).

Cell prepara-

tions were made only from rats weighing between 130 gms and
150 gms in the testing of FMS lipolytic activity on adipocytes (FMS target cells).
While the cell suspension was gently stirred, a 1.0
ml aliquot was withdrawn into a siliconized glass pipette,
added to isotonic saline, and the volume brought up to 10.0
ml.

A 1.0 ml aliquot of this stirred suspension was with-

drawn into a siliconized glass pipette, added to isotonic
saline, and the volume brought up to 10.0 ml; obtaining an
overall dilution of 1:100.

This same double step dilution

method was repeated when using Krebs-Ringer phosphate buffer
as the diluent.

The dilution was such that the cell concen-
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tration in the 0.5 ml sample to be monitored would fall between 1,000 and 80,000 cells.
Agitation is often required to maintain uniformity in
suspensions containing particles over 5 microns.

Mainte-

nance of an uniform cell suspension during counting was
achieved via continued gentle agitation during the process.
The desired control settings were chosen and the count cycle
initiated.
Sixteen counts per threshold level (272 counts in
total) were taken for each and every cell suspension preparation used for an in vitro bioassay of FMS.

For one-half of

these counts isotonic saline was used as diluting fluid
(electrolyte) and for the other half, Krebs-Ringer phosphate
buffer was used.
On every cell suspension preparation the cell number
per unit volume of cell suspension was calculated, and the
average diameter of the cells in the cell suspension calculated.

A frequency distirubtion of cell diameters was pro-

vided graphically for each cell suspension preparation.
Glycerol Determination
The biological activity of FMS was also measured, in
vitro, by its ability to increase the release of glycerol
from epididymal fat cell suspensions of the rat in a medium
of Krebs-Ringer phosphate buffer (pH 7.4) containing 4%
bovine

ser~~

albumin.

The amount of glycerol released into

the medium was determined by the method of Davidson and
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Karjala (1970), with modifications.

The assay utilizes the

fluorometric measurement of the reduced adenine

dinucleotid~

NADH 2 , formed when glycerol is oxidized to dihydroxyacetone
by glycerol dehydrogenase.
Reagents
1 N Perchloric Acid:

44.8 ml of the 70% (11.14 N), per-

chloric acid was dissolved into distilled water and diluted
to 500.0 ml with distilled water.
1.8 N KOH:

249.3 gms of 45% (w/v) KOH was mixed with dis-

tilled water and diluted to 1.0 liter with distilled water.
Glycerol, Stock solution:

3.68 mg of glycerol was dissolved

into distilled water and diluted to 100.0 ml with distilled
water.

Stock solution; 0.4 umole/ml.

Glycerol Standards:

Standard solutions of glycerol were

prepared ranging from 0.04 to 0.40 umole per tube.
0.1 M Glycine buffer, pH 9.5:

751 mgs of glycine, ammonia-

free, was dissolved into distilled water and diluted to
100 ml with distilled water.

The pH was adjusted to 9.5

with 0.1 M NaOH.
NAD:

3.0 mg of coenzyme NAD per ml of 0.1

~glycine

buffer,

pH 9.5 was prepared just prior to incubation.
Glycerol dehydrogenase:

0.15 Unit glycerol dehydrogenase

per ml distilled water.

1 Unit oxidizes 1 umole of glycerol

per minutes to dihydroxyacetone at pH 10.0 at 25°C.
An Aminco-Bowman Spectrophotofluorometer and Ratio
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Photometer were used to measure the relative fluorescence
intensity of NADH

2

with excitation set at 350 nm and an

emission setting of 455 nm.

The "Sensitivity" control on

the ratio photometer was set at 3.

The "Sensitivity Ver-

nier" control was set at its counterclockwise limit.
Preparation of Standard Curve
Standard samples for the preparation of a standard
curve were prepared by diluting various aliquots of the
stock glycerol standard solution to 1.0 ml with distilled
water in glass stoppered 17 x 135 mm Corning centrifuge
tubes.

Standard glycerol solutions were prepared ranging

from 0.04 to 0.40 umole of glycerol per tube.

One ml of

distilled water was used as the enzyme-coenzyme blank.
This 1.0 ml of distilled water, because it is carried
through the deproteinization procedure along with the glycerol standards, is referred to as deproteinized water in
the table on "Blank and Sample Protocol for the In Vitro
Bioassay of Fr-1:S".

The glycerol standards were treated in

the same manner as the unknown samples to compensate for any
loss of substrate which may occur to the unknown samplesduring their deproteinization.

When glycerol dehydrogenase

(enzyme) and NAD are kept separate the fluorescence of each
remains constant, but when the two are incubated together a
small gradual increase in fluorescence occurs.

Withaddition

of 1.0 ml of distilled water (carried through the deproteinization procedure) the resulting fluorescence is slightly
greater.

As a result an enzyme-coenzyme blank must be sub-
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tracted from all standard and unknown sample readings.

A

sample blank must also be subtracted from the corresponding
unknown sample reading.
Deproteinization was achieved by adding 2.0 ml of 1 N
HC10

4

to each standard and enzyme-coenzyme blank.

The con-

tents were mixed for 30seconds with a vortex mixer and then
centrifuged for 15 minutes in an IEC Clinical Centrifuge
(setting 6:

809 head).

The standard and blank solutions

were then very carefully transferred to a new set of glass
stoppered 17 x 135 mm Corning centrifuge tubes.

1.0 ml of

1.8 N KOH was added to each glycerol standard and theenzymecoenzyme blank to neutralize the standards and blank to pH
7-8.

The tubes were then cooled in ice for 10 minutes to

ensure complete precipitation of potassium perchlorate and
afterwards centrifuged for 10 minutes in an IEC Clinical
Centrifuge.

The resulting supernatant was decanted into a

4.0 ml volumetric flask and brought up to 4.0 ml in volume
with distilled water.

Final volume was 4.0 ml for all the

standards and enzyme-coenzyme blank.
1.0 ml aliquots from each deproteinized standard and
enzyme-coenzyme blank were placed in 17 x 135 mm graduated
reaction tubes.

6.0 mg of NAD in 2.0 ml of 0.1 M glycine

buffer, pH 9.5, was added to each reaction tube and to the
enzyme-coenzyme blank.

0.15 Unit of glycerol dehydrogenase

dissolved in 1.0 ml of distilled water was added to each
tube and to the enzyme-coenzyme blank.

After the above

additions the standards and the enzyme-coenzyme blank were
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incubated in a thermo-regulated v.rater bath set at room
temperature, 25°C, using air as the gas phase for 90
minutes.

The assay was performed at room temperature to

avoid the variable cooling of the reaction mixtures between incubation and reading.

The completeness of the re-

action and the stability of NADH
of exact timing.

2

eliminate the necessity

With the monochromator wavelength settings

of excitation 350 nm and emission at 455 nm, the relative
fluorescence intensity of each unknown sample was read
quickly to avoid errors in measurement due to possible heating of the samples in the cell chamber.
Thr fluorescence of each solution was read with excitation at 350 nm and emission at 455 nm.

The fluorescence

of the enzyme-coenzyme blank was subtracted from each standard using the ratio photometer's "Blank Subtract" control.
Figure 2 shows a linear relationship between relative fluorescence intensity and the concentration of glycerol within
the range of 0.01 to 0.10 umole of glycerol per tube.

The

data for this standard curve appear in Table 3.
Determination of Biological Activity of FMS Based on Glycerol Release from Epididymal Fat Cells
1.0 ml of epididymal fat cell suspension was placed in
a 25 ml Erlenmeyer flask containing 3.0 ml of Krebs-Ringer
phosphate buffer with 4% albumin.

After 100 ug of FMS (or

test material) in 1.0 ml of Krebs-Ringer phosphate buffer
was added to the flask, incubation was allowed to proceed
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TABLE 3
Standard Curve Data for
Determination of Glycerol

Glycerol
umole

No. of
Determinations

Relative
Fluorescence
Intensity

0.01

20

0.8

0.02

20

1.6

0.03

20

2.4

0.04

20

3.2

0.05

20

4.0

0.06

20

4.8

0.07

20

5.6

0.08

20

6.4

0.09

20

7.2

0.10

20

8.1

Instrumental Parameters:
(1)

A~inco

(2)

Slit No:
Slit size (mm)

Ratio Photometer - photomultiplier
tube detector (PMT):
R 456 (unpotted) PM tube and Cable PM tube
3

4

7

2

2

2

(3)

Excitation wavelength
Emission wavelength
Xenon Lamp Cat. No.

350 nm
450 nm
416-922

(4)

Sensitivity setting 3
Sensitivity vernier setting - Counterclockwise
limit
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for 3 hours at 37°C in a Dubnoff Metabolic Shaker using air

as the gas phase.
At the end of the incubation, a 1.0 ml aliquot was
withdrawn from each of the incubation flasks and placed in
glass-stoppered 17 x 135 mm Corning centrifuge tubes.

The

remaining contents from all the incubation flasks were pooled
and 1.0 ml of the pooled incubation mixtures pipetted into a
centrifuge tube to serve as the sample blank, which must be
subtracted from each of the unknown sample readings.

In

addition, 1.0 ml of distilled water was pipetted into a
Corning centrifuge tube to serve as the enzyme-coenzyme
blank.

(A minimum of four glycerol standards (two pair),

one enzyme-coenzyme blank, and one sample blank were prepared per assay.)
The protocol for the in vitro bioassay of FMS based on
glycerol release is given in Table 4.
the

sru~ple

The fluorescence of

blank was subtracted from the final reading of

each unknown sample.

The amount of glycerol present in the

sample was calculated by reference to the standard curve of
relative fluorescence intensity versus glycerol concentration.

The total glycerol released into the medium as umoles

was calculated by multiplying the concentration valueobtained
from the standard curve by the dilution factor.

Glycerol

release was expressed umoles of glycerol released by 100 ug
of FMS (or test material) acting on rat epididymal adipose
tissue fat cell suspension equivalent to 1 gram of lipid for
3 hours at 37°C.
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TABLE 4
Protocol for the
In Vitro Bioassay of FMS

Enzyme-Coenzyme
Blank
Deproteinized
Pooled sample

Sample
Blank

Sample

Standard

1.0 ml
1.0 ml

Deproteinized
Sample

1.0 ml

Deproteinized
Standard
Deproteinized
H 0
2
NAD

1.0 ml
2.0 ml

2.0 ml

2.0 ml

Enzyme

1.0 ml

1.0 ml

1.0 ml

H 0

2

3.0 ml

Final reaction mixture contained 6.0 mg of NAD and 0.15 U
glycerol dehydrogenase in a total volume of 4.0 ml of 0.05
M glycine buffer, pH 9.5 and incubated at 25°C for 90
minutes.
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Purification of Crude FHS by Ultrafiltration and Column
Chromatography
After assaying, on an individual basis, the crude FMS
extracted from the urine of each group of rats, all the
reamining crude FMS was pooled, dissolved in deionized water
and the solution was lyophilized in a VirTis Uni-Trap Freeze
Dryer (The VirTis Company, Inc., Gardiner, New York).

The

lyophilized pooled residue of crude FMS was then divided
into three parts and each of the three parts was carried
through an ultrafiltration procedure, separately, employing
PM-10 and UM-2 Diaflo

membranes.

PM-10 Diaflo Membrane
A 0. 05%(w/v) to 0.5%

(w/v) aqueous solution of crude

FMS was transferred to an Amicon Stirred Standard Ultrafiltration Cell, Model 52 (Amicon Corporation, Scientific
Systems Division, Lexington, Massachusetts), fitted with a
PM-10 Diaflo Membrane, which has a molecular weight cut-off
of 10,000.

A pressure of 30 psi was applied and the cell

stirred at a relatively high rate.
Ultrafiltration was allowed to proceed for about 1.5
hours at an environmental temperature of 0° to 5°C.

The

ultrafiltrate and the residue were freeze-dried in the
VirTis Uni-Trap Freeze Dryer, and bioassayed in vitro for
lipolytic activity.
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UM-2 Diaflo Membrane
The biologically active fraction, the PM-10 filtrate,
was then subjected to ultrafiltration, in a like manner,
using a UM-2 Diaflo Membrane, with a cut-off at 1,000 in
molecular weight.

The ultrafiltrate and the residue were

freeze-dried in the VirTis Uni-Trap Freeze Dryer and bioassayed in vitro for lipolytic activity.
DM-5 Diaflo Membrane
The biologically active fraction, the UM-2 residue,
was further purified and the molecular weight of FMS further approximated by subjecting this fraction to ultrafiltration using the newly patented DM-5 Diaflo Membrane, with
a cut-off at 5,000 in molecular weight.

The DM-Series is

similar to the UM series of membranes in flow rate and rejection characteristics, and exhibits resistance to detergents, salts and phosphates, which affect the UM structure.
The UM-2 residue was subjected to ultrafiltration with the
DM-5 membrane in the same manner as with the PM-10 and UM-2
membranes and the ultrafiltrate and residue bioassayed as
before.
Bio-Gel P-10
A 0.35% (w/v) aqueous solution of UM-2 residue, the
biologically active fraction from the ultrafiltration with
the UM-2 Membrane, was passed through a column (K 25/45,
2.5 x 45 em, jacketed, Pharmacia Fine Chemicals Inc.,
Piscataway, N.J.) of Bio-Gel P-10 fitted with a Pharmacia
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Flow Adaptor, A-25.
.
. d at 0° Th e temperature o f t h e co 1 urnn was ma1nta1ne
5°C.

Elution with distilled water was carried out at a

rate of 1.8 rnl per minute and serial fractions 5 rnl in volume were collected with an Unifrac Fraction Collector
(Savant Instruments Inc., Hicksville, New York}.

The trans-

mission of the effluent at 280 nm was monitored with a LKB
Uvicord

~Jsorptiometer

Rockville, Maryland}.
(100 tubes}.

and Recorder (LKB Instruments Inc.,
The total volume of eluate was 500 rnl

The collected fractions corresponding to in-

dividual elution peaks were pooled and lyophilized in the
VirTis Freeze Dryer.

Each peak

~·ms

bioassayed in vitro for

lipolytic activity.
Sephadex G-50 and Bio-Gel P-10
A 0.01% (w/v} aqueous solution of UM-2 residue, the
biologically active fraction from the ultrafiltration with
the UM-2 Membrane, was passed through a prepared column
(K 25/45, 2.5 x 45 ern, jacketed, Pharrnacia Fine Chemicals
Inc., Piscataway, N.J.} of Sephadex G-50 and then through a
column (identical in type to the one just mentioned} of BioGel P-10, in tandem, as per Kwok (1974}.
The column procedure used was that of Kwok (1974}.
With the temperature of the column maintained at 0°-5°C
elution with distilled water was carried out at a rate of
2.5 rnl per minute and serial fractions 5 rnl in volume were
collected with the Unifrac Fraction Collector.

The trans-

74
mission of the effluent was monitored with the Uvicord
Absorptiometer and Recorder, set for monitoring at 280 nm.
The total volume of the eluate was 500 ml (100 tubes) .

The

fractions corresponding to elution peaks were pooled and
lyophilized in the VirTis Uni-Trap Freeze Dryer, followed
by in vitro bioassay for lipolytic activity.

A diagram of

the scheme for the extraction of crude FMS from rat urine
and purification of FMS via ultrafiltration and column chromatography is shown in Figure 3.
Isoelectric Focusing
Isoelectric focusing has become, in recent years, a
powerful tool for the analytical or preparative separation
of ampholytes, especially proteins, and for the characterization of the ampholyte by determining its isoelectric point
(pi).

The technique is characterized by a very high analy-

tical resolution and by simplicity of apparatus and method.
Isoelectric point determinations of resolved proteins can
now be accomplished conveniently and with great reproducibility in a single experiment.

Proteins with as small a

difference as 0.02 pH unit separating their isoelectric
points have been successfully resolved.
Isoelectric focusing is obtained by imposing a direct
current potential on a system of electrolytes.

The whole

interval between the electrodes is occupied by a series of
ampholytes with pi ascending from anode to cathode, thus
creating a pH gradient defined in each point by carrier
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FIGURE 3
Urine from Fasting Rats
pH 5.3
Benzoic Acid
Benzoic Acid Precipitate
3x Ethanol Wash
Residue
Distilled Water
Water Soluble Fraction
pH 5.3
2 Vol. Ethanol
Alcoholic Precipitate
Distilled vJater

Aqueoul

Extract
Lyophilization

Crude FMS
PM-10 Diaflo Membrane
PM-10 Ultrafiltrate
Bio-Gel P-10
Eluate
Lyophilization
FMS

I

UM-2 Diaflo Membrane

UM-2 residue ---- DM-5 Diaflo Membrane
Sephadex G-50
Bio-Gel P-10
Eluate
illi-5 Residue

I

FMS

Lyophilization

I Bio-Gel P-3..0

Eluate
Lyophilization
FHS

Flow Diagram for Isola·tion .and Purification of F:-.IS
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a1npholytes which are in their isoelectric states.

Each site

along the gradient has its pH determined by the pH of the
ampholyte at that point.

When one adds a mixture of proteins

with isoelectric points occurring within the pH range of the
pH gradient, each protein molecule of the mixture migrates
towards the pH value in the column where its net charge is
zero.

The pH gradient reaches a stable equilibrium if the

system is stable for the duration of the experiment.

Each

protein of the mixture will be resolved at the point in the
electrofocusing column where the pH is equal to the pi.

Since

this focusing, or resolution of proteins, is caused by an
electric field, it has been named "Isoelectric Focusing".
Ampholine Carrier Ampholytes
Carrier ampholytes covering a pE range from pH 3 to
pH 10, manufactured and marketed by LKB - Produkter AB, S-161
25 Bromma Sweden, were obtained from LKB Instruments, Inc.,
Rockville, !1aryland, under the trade name of Ampholine Carrier
Ampholytes, pH range 3-10.

These synthetic ampholytes are

aliphatic polyamino-polycarboxylic acids composed of a very
large number of homologues and isomers of the same type of
molecule which exhibit different, closely spaced pK and pi
values.
The ready-for-use mixture came in a 25 ml bottle at a
concentration of 40%

(w/v) water solution, and was stored in
0

the dark at a low temperature (below 6 C) to prevent decomposition, discolorization, and contamination by microorganisms.
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The recommended concentration for electrofocusing
proteins is 1 gm of Ampholine per 100 ml of solution.

A 2%

(w/v) ampholine solution was used when electrofocusing FMS
in order to increase protein solubility.

Ampholine chemi-

cals contribute to the solubility of proteins.
Electrode Solutions
Because the electrodes can communicate directly \.Yi th
the separation compartment, the carrier ampholytes adjacent
to the electrodes must be protected from anodic oxidation
or cathodic reduction.

This is accomplished by surrounding

the anode with a dilute solution of phosphoric acid and the
cathode with a dilute solution of sodium hydroxide.
Electrolysis, during the electrofocusing experiment,
drav;s the dilute acid and base solutions to their respective
electrodes; the dilute phosphoric acid solution giving a net
positive charge to any nearby carrier ampholytes, causing
them to be repelled from the anode and hence protectedfrom
electrolytic decomposition.

At the cathode, the diluteNaOH

solution, gives a negative charge to the nearby carrier
ampholytes which are then repelled from the cathode.
Phosphoric Acid Solution:

Anode Electrode Solution

The solution was composed of 0.2 ml phosphoric acid,
14.0 ml distilled H 0, and 12.0 gms of sucrose.
2

Thedistil~

ed water was added to a 50 ml graduated cylinder containing
12.0 gms of sucrose.

The graduate cylinder was shaken manually
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until the sucrose was completely into solution.
phosphoric acid was then added.

0.2 ml of

The final solution volume

equalled 23 ml.
Sodium Hydroxide Solution:

Cathode Electrode Solution

0.2 gm of NaOH pellets was dissolved into 20 ml of
deionized H 0 contained in a 30 ml Pyrex beaker.
2

The entire

volume of NaOH solution was pumped on to the isoelectric
column.
Density Gradient
In order to prevent the remixing of separated zones due
to thermal covection, and to stabilize the carrier ampholytes
and protein sample zones, a density gradient of sucrose was a
necessary prerequisite for the present technique.

Any non-

ionic substance harmless to the sample and pH gradient can be
used for preparing a density gradient.
A linear density gradient was prepared by mixing a
light solution containing distilled water, ampholytes, and
sample (FMS), and a dense solution containing distilled water,
ampholytes, and a "dense" solute (sucrose) with an LKB Gradient Mixer (LKB Instruments, Inc., Rockville, Haryland) designed specifically for filling the electrofocusing column.

With

the Tygon tube and outlet tube clamped with pinch clamps the
dense solution was added to the vessel that holds the spiral
stirrer, followed by the addition of the light solution to
the vessel that holds the tappered cone.

The stirrer and cone

were then placed into the vessels and the stirrer motor started
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The pinch clamp between the light and dense solution vessels

of the gradient mixer was loosened, quickly followed by the
loosening of the clamp on the outlet tubing leading from the
dense solution of the gradient mixer to the pump.

A flow

rate of 1 ml per minute was used.
It took approximately 2 hours to fill the column.

When

the outlet tubing is first opened only liquid from the stirrer
vessel flows through the outlet tubing.

As the column is

filled there is a continuous decrease in the density of the
liquid until only the light solution passes through the outlet
tubing, resulting 1n a gradually decreasing sucrose concentration from the bottom to the top of the isoelectric focusing
column.
Dense Solution:

2% Ampholine

Three fourths of the total amount of carrier ampholytes
(3.75 ml of 40% (w/v) ampholine solution), pH 3 to pH 10 was
placed into a 100 ml graduated cylinder and diluted up to 42
ml with distilled water.

28 grns of sucrose were dissolved in

this solution by gentle warming and stirring, which gave a
final total volume of 60 ml to this mixture.

Of this mixture

5.0 ml was discarded, the remaining 55 ml was added to the
gradient mixer, placing it into the vessel that holds the
spiral stirrer.
Light Solution:

2% Ampholine

One fourth of the total amount of carrier ampholytes
pH 3 to pH 10 (1.25 rnl of 40% (w/v) ampholine solution) was
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placed into a 100 ml graduated cylinder and diluted up to 60
ml with distilled water.

After this solution was thoroughly

mixed, 5.0 ml was discarded, leaving a total of 55 ml of light
solution which was added to the gradient mixer in the vessel
that holds the tapered cone.
Sample
15 to 20 mgs of FMS were added to the light solution of
the gradient mixer just prior to filling the column.
Experimental Protocol
The entire electrofocusing column (LKB 8100

~mpholine

Column, LKB Instruments, Inc., Rockville, Maryland) was thermostated at 4°C by utilizing a cryostat (Tamson Thermostatic
Bath (TM-9) and circulator (PBC-4, Neslab Instruments, Inc.,
Portsmouth, New Hampshire), which circulated coolant around
both the inner and outer electrofocusing columns.

The coolant

consisted of equal volumes of distilled water and ethylene
glycol.
The central electrode valve was opened by depressing
the spring located at the top of the glass column tube.

This

helical spring is in the setting device connected to the upper
end of a Teflon rod that serves as a lever for the valve at
its lower end.

The central electrode is wound aroung this

Teflon rod which lies within the central tube.

The valve

makes it possible to shut the central tube off from the separation compartment when emptying.
the valve normally closed.

The helical spring keeps
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The anode electrode solution was pumped into the cen-

tral electrode compartment, at top speed, via the upper

nippl~

with an LKB 12000 Vario-Perpex pump (LKB Instruments, Inc.,
Rockville, Maryland).

The central electrode served as the

anode during the isoelectric focusing of FMS.

The pump tubing

was inserted all the way down to the bottom of the central
electrode compartment.

While filling, a few drops were allow-

ed to come out of the bottom of the column via the small piece
of capillary tubing, which was then clamped shut again.
In preparation to fill the separation compartment, the
dense solution was added to the stirrer vessel on the LKB Gradient Mixer, followed by the addition of the light solution
to the cone vessel.

After the stirring motor was turned on,

the peristaltic pump was hooked up to the gradient mixer and
set at 4 x 10, equalling a filling rate of 72 ml per hour.
The polyethylene tubing was inserted about 2 inches into the
lower nipple and against the side of the glass; thereby, preventing the drops from falling and making the gradient uneven.
FMS was added to the light solution and the clamps
between the light and dense solution vessels loosened.

Then,

quickly, the clamp on the outlet tubing leading from the dense
solution of the gradient mixer to the pump was loosened.
After approximately 2 hours the solution mixed on the LKB Gradient Mixer filled the electrofocusing compartment giving a
linear density gradient.
shut off.

The pump and the gradient mixer were
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The remaining space at the top of the electrofocusing

column was filled with the cathode electrode solution which
was pumped on top of the gradient at a pump speed setting of
2.5 x 10 (a filling rate of 45 ml per hr).

The column was

filled until the cathode solution level reached the uper
black line about 1 inch above the upper platinum electrode.
The electrodes were then connected to an electrophoresis power supply (Gelman Instrument Co., Ann Arbor, Michigan),
the anode electrode to plus via the plug at the central eletrode terminal located on the very top of the column, and the
cathode electrode to minus via the plug at the upper electrode
terminal located by its loop located at the top of the column.
After the electrodes were in proper position they were
tied to the supporting rack to make them immovable.

The power

supply was turned on and the voltage increased to a constant
voltage of just under 500 volts.

Upon completion of this last

step, the electrofocusing of FMS has begun; a pH gradient is
gradually being created and FMS is starting to migrate towards
the point in the gradient corresponding to its isoelectric
point.
At first, the current on the milliampere meter read 10
to 12 rna.

This is because the water and the carrier ampho-

lytes inside of the column are all intermixed.

When the cur-

rent (at a constant voltage of 500 volts) had decreased to a
constant value of 2 rna most of the carrier ampholytes in the
system had migrated at or near their isoelectric points.

The

FMS sample had also been focused at its isoelectric point to
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a great extent; however, it took 48 hours to reach a steady
final focusing.
Final movement to the equilibrium state is slow, and
the contribution of FMS to the conductance extremely low.

As

a result the change in conductivity time was so small after
the current had decreased to the constant value of 2 rna, that
no further current change registered in the time remaining
for final completion of the electrofocusing run.

In general,

the focusing requires 10 hours or more extra time after the
current has decreased to a constant value.

An electrofocusing

run normally takes from 24 to 72 hours at a voltage of 300 to
500 volts, depending on the ampholine pH range used.

Longer

electrofocusing times are required for resolution of proteins
in narrower pH ranges of ampholines.
When the electrofocusing was completed, the central
electrode valve was closed.

Extreme care was taken to release

the spring pressure very carefully, to prevent the gradient
from being disturbed by bubbles which would result in incorrect pH values of the effluent fractions due to their contamination with the anode electrode solution.

The voltage was

turned off and the jacks disconnected from the column.

Then,

at the fastest rate, the central electrode solution was pumped
out of the column to prevent any leakage of the solution out
of the central tube.
After a thorough rinsing of the polyethylene tubing,
the tubing was connected from the fraction collector to the
electrofocusing column.

The connection tubing was as short
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as possible to prevent mixing.

With 80 collection tubes in

the fraction collector rack, the fraction collector was turned
on.

The counter on the fraction collector was set at 20 drops

per fraction (1.8 ml per tube).
The outlet clamp for the electrofocusing colQmn was
then opened and the column was emptied by means of an LKB
peristaltic pump set a 1.4 x 10 (a speed of approximately 22
ml per hour) .

It took about 6 hours to empty the entire

column.
The effluent was monitored with an LKB Absorptiometer,
set for monitoring the effluent at 280 nm.
The "Ambient Temperature" knob on the LKB Uvicord II
Photometric Flow Analyzer was set at 1, for use at a coolant
temperature 4 degrees centigrade.

While the first fraction

was being collected, the Uvicord was set at 2X the sensitivity
scale.

Once this was accomplished the "T%" was dropped back

from 100% T to about 40-45% T so the entire column could be
monitored.

If this is not done the collection won't be able

to be monitored.

A low reading of 40 to 45% T will be record-

ed for the first couple of fractions due to significantly high
values of absorption in that part of the gradient.

However,

after these first couple of fractions the absorption gets much
lower, and T% much higher.

If the recorder bar had been

originally set at 100% T the low absorption fractions would
cause the recorder bar to go "Off" scale, resulting in an unmonitored collection.
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I'ieasurement of pH

Measurement of the pH of the collected fractions provides a picture of the pH gradient, making it possible to
determine the isoelectric point of each component of the sample with the accuracy obtainable with the pH meter being used.
The pi is dependent on the temperature, but there is
no reliable factor which allows conversion of a pi measured
at one temperature to the pi corresponding to another temperature.

As a result the pH of the fractions from electrofocus-

ing were measured on a Beckman Phasar-1 pH Meter at the same
temperature as used during electrofocusing.
Data Analysis:

Measurement of the Result

The LKB Uvicord II Photometric Flow Analyzer records
the UV absorption curve on paper.

The volume of the eluted

liquid, or the corresponding length of the column in ern's,
is plotted along the x-axis.
on the same diagram.

The pH gradient is also plotted

The y-axis is divided into pH units,

starting with the lowest and ending with the highest values
of the pH gradient used.
Removal of Carrier Arnpholytes from F.HS Fractions
The FMS was separated from the sucrose and carrier
arnpholytes by means of dialysis using #3 Spectrapor Membranes
(Spectrum Medical Industries Inc., Los Angeles, California).
Since some of the Arnpholine carrier ampholyte molecules have
a molecular weight of more than 1000, they pass through the
dialysis membrane rather slowly.

Therefore, dialysis required
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48 hours before all the carrier ampholytes had been removed.
The dialyzing sacs were closed by using Spectrapor
Closures.

Spectrapor closures were used instead of tying a

knot in the wet tubing since knot tying can distort pores in
~et

tubing.

String tying was not used because the string can

cut tubing.
Protein Determinations
The protein concentrations of the fractions of FMS
obtained from electrofocusing were measured using the method
of Lowry et al.

(1951).

This very sensitive method is based

on the fact that a deep blue color is formed when protein in
alkaline copper solution is treated with the phenol reagent
of Folin and Ciocalteu (1927).
Two distinct steps are involved in the reaction.
First, the protein reacts with copper in alkaline solution,
and second, a reduction of phosphomolybdic and phosphotungstic acid by the copper-treated protein occurs.
Preparation of Standard Curve
Reagents
1% Sodium Dodecyl Sulfate (SDS):

1 gram of CH

3

(cH 2 ) 11 oso 3 Na

was dissolved in distilled water to a volume of 100 ml.
2% Sodium Carbonate in 0.1 N Sodium Hydroxide:

0.1 N NaOH was

prepared by adding 0.4 grams of NaOH to enough distilled water
to make 100 ml of solution.

2 grams of Na

2

co 3

were mixed with

a quantity of the 0.1 N NaOH solution sufficient to give 100
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ml of solution.

This reagent was prepared fresh just before

use.
2% Sodium Tartrate:

2 grams of Na c 4 H o · 2 H2 o v1ere dissolved
2
4 6

in distilled water and the solution diluted to 100 mls with
distilled water.

1% Copper Sulfate:

1 gram of cuso ·5 H 0 was dissolved in
2
4
distilled water and the solution was diluted to 100 mls with
distilled water.
Phenol Reagent of Folin and Ciocalteu, lN:

A commercially

prepared solution of the phenol reagent, 2 N, was purchased
from Harleco, Philadelphia, Penn.

A working solution was pre-

pared from this, each day of use, by diluting a small volume
of the stock solution with an equal volume of water to give a
1

~phenol

reagent.

Standard Protein Solution:

Crystallized human albumin, pur-

chased from Dade Division of American Hospital Supply Corporation, Miami, Fla., was used for the preparation of a standard
protein solution.

1'7hen reconstituted with 3. 0 ml of distilled

water, the standard contains 80 mg of protein per ml.
Working Standard Protein Solution:

A working standard protein

solution of 80 ug/ml was prepared just before use by diluting
0.1 ml of the protein standard solution to 100.0 ml with dis-

tilled water.
Procedure
Standards for the preparation of the standard curve
were prepared by diluting various amounts of the working

standard solution to 1.0 ml with distilled water.
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One ml of

distilled water was used as blank.
To 100 ml of the 2% sodium carbonate in 0.1 N sodium
hydroxide, 1.0 ml of 2% sodium tartrate and 1.0 ml of 1%
copper sulfate were added, and thoroughly mixed.

Five ml of

this mixed reagent was then added to each blank and standard.
After mixing, they were left to stand at room temperature for
10 minutes.
One-half ml of the 1
tube and mixed

~

i~mediately.

phenol reagent was added to each

After 30 minutes or longer the

absorbance was measured at 700 nm in a Beckman DB Spectrophotometer.

The data for this standard curve appear in Table 5.

A linear relationship between the absorbance at 700 nm and the
concentration of protein within the range of 16 ug to 80 ug is
shown in Figure 4.
Determination of FMS Protein Concentration
1 mg from each of the fractions of FMS obtained from
electrofocusing was added to. distilled water, and the volume
then adjusted to 10.0 ml.
Various aliquots of the same FMS test solutions

were

diluted to a total volume of 1.0 ml with distilled water and
analyzed for protein content.

The amount of protein

was calculated by reference to the standard curve.

p~esent
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TABLE 5
Standard Curve Data for
Determination of Protein Concentration

Micrograms
of Protein

No. of
Determinations

Absorbance*
700 nm

16

5

0.014 + 0.001

32

5

0.061 + 0.002

48

5

0.114 + 0.008

64

5

0.160 + 0.005

80

5

0.216 + 0.002

* Jl.1ean + Standard Deviation
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Polyacrylamide Gel Electrophoresis of FMS
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The fractions of FMS obtained from electrofocusing were
subjected to polyacrylamide gel electrophoresis utilizing a
Hoefer Disc Electrophoresis Unit (Hoefer Scientific Instruments Co., San Francisco, California).

Anionic polyacryl-

amide gels were used for the electrophoresis.
Reagents
Stock Solutions
Stock solutions were prepared as

outlined in Table 6

using deionized water and were filtered and stored in brown
glass bottles or bottles wrapped in foil in the refrigerator.

Most of these stock solutions had a shelf life of up

to three months.
Working Solutions
Working solutions were prepared as outlined in Table 7
fresh from the stock solutions on the day they were to be
used.
Fixative, Fixative-Stain, and Destaining Solution
The fixative solution and the solution for washing and
destaining the polyacrylamide gels were prepared in advance
and stored at room temperature, Table 8.

The Coomassie

Brilliant Blue R-250 was prepared as an aqueous stock solution which was stirred and filtered prior to use.

This

stock solution was diluted 1:20 with 10% trichloroacetic
acid (TCA) just prior to staining the gels.

The fixative
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TABLE 6
Anionic Gel Stock Solutions

Separation Gel
(Small-pore gel)

Sample and Stacking Gels
(Large-pore gels)

(A)*

(B)

1 N HCl
approx. 48 ml
Trizma-Base
36.3 gm
0.46 ml
water to
(pH 8. 9)

100.0 ml

*

30.0 gm
0.8 gm

Potassium Ferricyanide

0.015 gm
100.0 ml

*

Acrylamide
BIS

water to

10.0 gm
2.5 gm

100.0 ml

(F)

(E)

Ammonium Persulfate 0.14 gm
water to

100.0 ml

(D)

BIS

water to

water to
(pH 6. 7)

(C)

Acrylamide

1 N HCl approx. 48 ml
Trizma-Base
5.98 gm
TEMED
0.46 ml

100.0 ml

Riboflavin
water to

0.004gm
100.0 ml

*pH adjusted by titrating with 1 N HCl before dilution to
100 mls.
TEHED- N,N,N',N'-Tetramethylethylenediamine
BIS - N,N'-Methylene-bisacrylamide
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TABLE 7
Anionic Gel Working Solutions

Separating Gel
(Small pore gel)

Sample and Stacking Gel
(Large-pore gel)

Buffer
Solution

1

Part

A

1

Part

B

TRIZHA-BASE 6. 0 gm

2

Parts

c

2

Parts

c

Glycine

4

Parts E

1

Part

F

Water to 1 liter

1

Part

4

Parts Water

Water

pH 8.9 (8.8-9.0)

pH 6.7 (6.6-6.8)

pH 8.3

28.8 gm
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TABLE 8
Fixative, Staining and Destaining Solutions

Fixative Solution
TCA

10%
Fixative-Stain Solutions
Coomassie Brilliant Blue

Stock Solution:
Coornassie Brilliant Blue 1 grn
Water to
100 ml
Working Solution:
12.5-20.0% TCA*
Stock Solution

20 rnl
1 rnl
Destaining Solution

TCA

10%

* A further increase in sensitivity can be
achieved by the use of a 20% TCA dye solvent.
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stain solution was made up fresh from the stock solution
before use.
Procedure
Twelve Pyrex glass columns (10 em long and having an
inner diameter of 0.5 em and an outer diameter of 0.7 em)
were acid cleaned and coated with a wetting agent (1 part
Kodak Photo-Flo to 200 parts water) .

Base caps (vacutainer

tops) were placed at one end of the gel columns which were
then placed into a loading rack in which front-to-hack
vertical alignment of the gels could be assured.
Stock solutions A, C, and E were removed from the
refrigerator and 4 ml of solution A, 16 ml of solution E,
8 ml of solution C, and 4 ml of deionized water were placed
in separate flasks and allowed to warm up to room temperature.

Approximately 20 mls of separation gel solution was

the volume required to run twelve 10 em long gels.

The

four components were then added to a single flask and
swirled gently to prevent air bubble formation and to provide thorough mixing.

This was the separation gel solution.

Using a 1 ml tuberculin syringe, to which 5 em of Tygon
tubing was attached, exactly 1.6 ml of the separating gel
solution was dispensed (without bubble formation)

into each

of the 12 vertical gel columns.
An

Oxford pipette was then used to carefully layer 100

ul (2-3 rom) of water on top of the gel solution.

If the gel

columns are not coated with a wetting agent prior to their
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use, a bolus of water will form which \vill drop into the gel

solution and dilute it.

However, if the gel columns are

coated, water will layer evenly on top of the unpolymerized
gel solutions.

The purpose of the water layering of gel

solutions is that it prevents a gel-air meniscus and produces a flat gel surface which is essential for obtaining
good protein band formation.

It also prevents oxygen, which

retards gel formation, from diffusing into the gels.
The separation gels were left undisturbed for one half
hour during which time complete chemical polymerization
occurred as was evident by the visibility of a distinct
refractile line between the gel and water interface.
The gel columns were then removed from the loading
rack and the water layer was removed by giving the column a
quick flick of the wrist.

The lip of the gel column was

then touched to a piece of absorbent paper to remove the
last traces of water.
Two milliliters of solution B, 4 ml of solution D, 2 ml
of solution F, and 8 ml of water were pipetted into another
set of small flasks.

These solutions were warmed to room

temperature and gently mixed in a flask that was completely
wrapped in foil to protect this gel solution from premature
photopolymerization.

This solution was to serve as the

photopolymerizing stacking and sample gel.

A 1 ml syringe

with Tygon tubing adapter was then used to add 0.3 ml of
this solution to each gel column.

This served as the
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stacking gel.

Once again, 100 ul of water was layered over

this gel solution as previously described.

The entire load-

ing rack was positioned approximately 30 ern from a fluorescent light source.

Fifteen minutes were allowed for photo-

polymerization to begin as evidenced by the appearance of
opalescence in the stacking gel.

When photopolyrnerization

had begun, the light source was moved to within 5 ern of the
columns and another 15 minutes were allotted to insure total
photopolyrnerization.

The water layer was then removed as

previously described.
Exactly 1.0 rng of the FMS preparation to be tested was
dissolved in 1.0 rnl of the stacking and sample gel solution
and 0.250 rnl of the solution was added on top of the stacking gel and layered with 100 ul of water.

The sample gel

was allowed to photopolyrnerize for 30 minutes while positioned 5 ern from the fluorescent light.
Bromphenol blue (0.1 to 0.2 rnl of a 0.001% solution),
serving as a tracking dye, was incorporated into the sample
gel solution prior to its addition to the gel column.

This

dye migrates faster than the fastest sample ion species.
The gel columns were then removed from the loading rack
and inserted into the holes of the upper bath stoppers
(sample gel uppermost).

After all the gel columns were in-

serted in this manner, buffer was added on top of the sample
gels, making certain that no air bubbles were entrapped in
the remaining space of the upper gel column.

The entire

upper bath assembly containing the gel columns was then
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lifted out and sufficient buffer solution was added to the
separation gels such that a hanging drop of buffer solution
remained at the bottom of all the gel columns.

It is

essential that no air bubbles are entrapped in the gel
columns.
The lower bath (containing the anode) of the Hoefer
Electrophoresis Apparatus was then filled with 1000 ml of
buffer solution.

The upper bath assembly was then carefully

placed into position making certain that no air bubbles had
formed at either end of the gel columns.

Air bubbles result

in uneven band formation because they prevent a uniform
current flow through the gels.

The upper buffer reservoir

was then filled with 500 ml of buffer solution.
The lid was then placed on the upper bath.
supply was connected.

The power

A current of 2.5 rna per gel column

provided for good resoltuon of protein bands.

Electropho-

resis was carried out until the now discrete front of tracking dye band had migrated to within
gel end.

~

inch of the separation

This required approximately 1 hour and 30 minutes

at 2.5 rna per gel column.
At the completion of electrophoresis, the power supply
was turned off and the electrode jacks were disconnected.
The gel columns were removed from the upper reservoir and
were placed in a wash tray containing ice-cold water.

The

gels remained immersed in the ice-cold water for 5 minutes
which was sufficient time for maximal gel contraction.

A

ten milliliter syringe fitted with an 18 gauge needle was
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filled with ice-cold water.

The gel columns were kept

submerged while the tip of this needle (beveled edge
towards the gel to avoid scratching the gel) was inserted
between the glass column and the gel.

The needle was in-

serted slightly beyond the sample gel of the gel column.
Keeping the gel columns submerged and the needle flat
against the glass surface, the entire gel column was rotated with one hand while the position of the needle was
maintained.

This freed the entire circumference of the

sample gel from the glass column.

Ice-cold water was con-

tinuously injected around the gel surface as the gel column
was rotated.

The water pressure freed the stacking and

separating gels and in a few moments the intact gel was
expelled from the separating gel end of the glass column.
The gels were quickly placed in a 10% solution of TCA
for a minimum of one hour to insure that the protein fractions were fixed uniformly.

The gels were then stained by

immersion into 20 ml of the Coomassie Brilliant Blue working
solution for another hour.

Minute protein bands were well

detailed in 20% TCA-Coomassie Brilliant Blue stain solutions.
Destaining was done by three consecutive immersions of the
gels into 10% TCA solution, each immersion lasting about an
hour.

The gels were then immersed into 10% TCA solution

and the TCA solution was changed every day for approximately
3 days.

When the section of a gel, containing no separated

fraction was completely clear of stain, the gel was transferred to a solution comprised of equal parts of glycerol

and deionized water.
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This allows for the storing of gels

without shrinkage.
Densitometry of Polyacrylamide Gels
Densitometry of the gels was performed with a Densicord
Model 542 Densitometer (Photovolt Corporation, New York,
N.Y.).

The proper response setting was chosen and the

stained separation gels were scanned over their entire
length by the Densicord.

The percentages of the various

fractions from the densitometer trace were determined by
establishing the area under the curve at all points.
Photography of Polyacrylamide Gels
A Polaroid camera with a close-up lens was a convenient
method of photographing stained polyacrylamide gels.

CHAPTER III
Results
Effect of Body Weight and Age of the Rat on the Bulk Urinary Excretion, Total and Specific Activity of FMS
Eleven groups of 30 male albino rats varying in mean
group weight from 152-416 grams were placed on a high fat
diet with water ad libitum for a 7 day period.

They were

then transferred from their individual screen bottomed
cages to individual metabolism cages, and their urine
collected during a 24 hour fast under cold stress.

The

urine from the rats within a group was pooled and the crude
FMS extracted, weighed, and bioassayed in vitro for lipolytic activity.

Several approaches were employed for testing

the lipolytic activity of the FMS preparations.
Depending upon group mean weight just prior to the 24
hour fasting period under cold stress, the assay data collected on each individual rat group was placed in one of
three weight, hence age, categories:

(Category 1) body

weight range, "150-250" grams; Mean age, 7 weeks:

(Cate-

gory 2) Body weight range, "250-350" grams; Mean age, 14
weeks:

(Category 3) Body weight range, "350-450" grams;

Mean age, 18 weeks or greater.
Performance of in vitro bioassay, initially by the
method Duncombe, afforded a convenient and rapid measurement of the quantitative release of FFA as index of the
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lipolytic activity of the FMS preparation obtained from
each rat group.

Table 9 shows the data obtained for each

of the three defined categories in terns of free fatty
acids released from epididymal fat pads of the rats 130150 grams in weight in a medium of Krebs-Ringer phosphate
buffer (pH 7.4) containing 4% bovine serum albumin.

Analy-

sis of variance showed the observed variation between activity values of each of the categories to be significant
(P < 0.05).

Student t-tests determined which specific

categories show significance and at which level (Category
I vs. II, P < 0.01; Category II vs. III, P = 0.05).
Decreasing levels of significance in lipolytic activity
are noted in association with increasing weight and age of
rats from which the FMS is isolated.
After initial bioassay in vitro, the following

~n

vitro bioassays utilized epididymal fat cell suspensions.
Considerably increased lipolysis by FMS target cells was
observed as reflected by sizably increased amount of FFA
released in response to the same preparations of FMS.
These results are attributable to an increased sensitivity
of isolated fat cells as opposed to intact fat pads to
lipolytic agents.

Data on these bioassays depict the

effect of weight and age on total urinary excretion of FMS
under three classifications, the effect of weight and
age on FMS bulk excretion (Table 10), FMS specific
lipolytic activity (Table ll) and FMS total lipolytic activity (Table 12).

Data in each of the three tables are

TABLE 9
ResponseofAdipose Tissue to FMS Isolated from Rats of Different Weight and Age
Category

Weight Range
(gm)_

Mean Age
(wks)

II
III

p vs

P vs Difference
Betw·een Category Means

Control

0.361 + 0.03**

Control
I

FFA*
(umoles)

-

150-250
250-350
350-450

7

14

18

0.519 + 0.05

-

p < 0.001
p

< 0.01

p

=

0.435 + 0.02

-

0.01

p

<

p

< 0.3

0.05

0.390 + 0.005

-

*

Expressed as umoles free fatty acids (FFA) released by 100 micrograms of test
material acting on 250 milligrams of rat epididymal adipose tissue for 3 hours
at 37°c.

**

Mean + standard deviation of the combined group means.

I-'
0

w
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TABLE 10
Effect of \"'eight and Age on the Bulk Excretion of FMS
Body
Weight
Category
(gm)
I.

Mean
Bulk Excretion
(mg/animal)
Category

Approx.
Age
(wks)

150-250

7

1.9

M
188
G

l)
2)
3)
4)

R

0

u
p

152
193
233
174

0.6
0.2
2.5
4.1

s
II.

250-350

14

2.0

M

301
l)
2)
3)
4)
5)

G

R

0

u
p

s
III.

260
329
329
253
336

350-450

0.2
2.8
1.4
4.1
1.7
18

4.2

M

398
G

R

0

u

p

s

l) 379
2) 416

5.0
3.3

TABLE 11
Effect of Wei,ght and Age on the Specific Activity of FMS
Body
Weight
Category
(gm)

Approx.
Age
(wks)

Control
I.
150-250

p vs
Specific Actlvity
p vs
Difference Between
(umoles)
Group
Category
Category Means
Control
FFA Glycerol
FFA Glycerol FFA Glycerol f2FA Glycerol
10.02
11.68

7

1. 61
2.32

P<O.OOl

P<O.OOS

P<O.OS
_J P<0.025

P<O.OOl

P<O.Ol
P<0.30

P<O.OS

M

188
1) 152
2) 193

IT.

3) 233
4) 17 4
250-350
14

11.69
*11. 59
11.56
11.38
12.20

2.42
2.29
2.15
2.42

P<O.Ol
10.91

2.15

.--1

M

301
1)

260

2)

m.

329
3) 329
4) 253
5) 336
350-450
18

*10.67
10.52
10.98
10.57
11.68
11.04

2.15
P<O.OO
2.08
2.15
2.22
P<O.OS
10.35

1.95

-I

.J

H

398

1) 379

*10.39
2.02
10.48
2) 416
*10.26
1. 88
10.26
-...
f-J
Specific Activity is expressed as umoles FFA and glycerol released by 100 ug of FMS 0
acting on rat epididymal fat cell suspension equivalent to 1 gram of lipid.
~
* Two sets of determinations were run on these rat groups.
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TABLE 12
Effect of Weight and Age on the Tofal Activity of FMS

Body
Weight
Category
(gm}
I.

Approx.
Age
(wks)

150-250

Total Activity
umoles/animal
Group
Category
FFA Glycerol
FFA Glycerol

7

18

4

19

5

43

8

M

188
1) 152
2) 193

7.0
*2.3
2.3
28.5
50.0

3) 233
4) 174
II.

250-350

1.5
0.5
5.4
9.9

14

M
301
1}

260

*2.1
2.1
30.7
14.8
47.8
18.8

2) 329
3} 329
4) 253
5} 336
III.

350-450

.43
5.8
3.0
9.1

18

M

398
1}

379

2) 416

*52.0
52.4
*33.9
33.9

10.1
6.2

Total Activity, calculated as weight of extract (mg)
times specific activity.

*

Two sets of determinations were run on these rat groups.
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delineated in terms of categorical means representative of
the average of the sum of individual group means comprising
each of the three categories, and mean bulk excretion level
(Table 10), mean specific (Table 11) and total (Table 12)
lipolytic activities for every animal group contained within
each of the defined weight-age categories.
Analysis of variance revealed a significant variation
in the degree of soecific lipolytic activity amongst the
three lots of FMS from the three defined weight-age categories, whether FFA (P < 0.001) or glycerol (P < 0.01) release
was employed as index of FMS lipolysis.

Thereupon, t-tests

were conducted to ascertain at what significance level which
specific categories are significantly different in lipolytic
activity.

Weight categories I and II were significantly

different in specific lipolytic activity for both FFA and
glycerol released by the isolated epididymal fat cells (FFA,
P < 0.01; glycerol, P < 0.05).
III the difference in

F~1S

Beb1een categories II and

lipolysis showed significance for

both indexes of lipolysis (FFA, P

<

0. 0 5; glycerol, P < 0. 01).

Regarding the specific activity data, Students t-test
performed on the mean specific lipolytic activity of means
(the mean of the sum of the 11 group means) and the Controls
showed a significant difference in lipolytic activity for
both indexes of lipolysis (FFA, P
0.001).

<

0.01; glycerol, P <
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Figure 5 illustrates the relationship between 'Specific
and Total Activity of FMS', dependent upon \veight and age
of the rat from which FMS is isolated.

FFA and glycerol

release are expressed in terms of umoles released per 100
micrograms of FMS acting upon epididymal fat cell suspen0

sion equivalent to 1 gram of cell lipid for 3 hours at 37 C.
Substantiated via the Analysis of Variance and Students
t-test performed on the specific activity data obtained for
each of the 11 rat groups, the histogram depicts a significant difference in Specific Lipolytic Activity amongst the
three defined weight-age range categories:
150-250 grams; Mean age, 7 weeks;
350 grams; Mean age, 14 weeks;

( 1) Weight

rang~

(2) Weight range, 250-

(3) Weight range, 350-450

grams; Mean age 18 weeks or greater.

In addition, the histo-

gram illustrates a highly negative correlation, to the same
degree of significance as established by the already performed statistical analyses, existing between FMS Specific
Activity and increasing weight-age of the rat.
A more pronounced effect exists between FMS Total
Activity (Total Activity, calculated as weight of FMS
extracted from the rat urine times specific activity) and
increasing weight-age of the rat.

However, for both indexes

of lipolytic activity, instead of a highly negative correlation between increasing weight and age of the rat, the
correlation is highly positive.
Decreasing 'Specific Activity' with increasing 'Total
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Variation of Specific and Total Lipolytic
Activities with Rat Body Weight and Age.
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Activity' was found in the 11 rat groups with increasing
weight and age.

The greatest specific activity was found

in the FMS isolated from rats weighing 150-250 grams with
a mean age of 7 weeks (Category 1).

In contrast, total

activity was found to increase with increasing weight and
age.

In comparison with rats weighing 150-250 grams and

7 weeks in age (Category 1), for rats weighing 350-450
grams with a mean age of 18 weeks or greater (Category 3),
the total activity doubled, both for FFA and glycerol
indexes of lipolysis.
In conjunction with the in vitro bioassays utilizing
the increased sensitivity of isolated adipocytes, examination of the lipolytic response of adipocytes to FMS in the
terms of their cell number and-size was studied.

Table 13

expresses in terms of FFA and glycerol release per 10 6
cells, specific lipolytic activity for each of the defined
weight-age categories.

It will be observed that fat cells

have the greatest apparent sensitivity to FMS that is
isolated from rats ranging 150-250 grams in weight.

As the

rats increased in weight and age the lipolytic response of
the adipocytes to their FMS extracts apparently decreased.
Cellularity was determined on every cell suspension
prepared for in vitro bioassay.

Figure 6 shows the combined

cell diameter frequency distributions of the individually
prepared fat cell suspensions used in the various bioassays.

TABLE 13
Response of Adipocytes to FMS Isolated from Rats of Different

Category
Control

Weight
Range (gms)

-

Age
(wks)

FFA
(umoles/10

6

cells/hr)*
-3

-

195.61 X 10

227.30 X 10-

3

+ .009

**

vJeight and Age

Glycerol
6 cells/hr)*
(umoles/10
-3
31.26 X 10
+ .008**

+ .005

45.04 X 10

-3

+ .008

41.74 X 10

3

+ .002

37.86 X 10

1

150-250

7

2

250-350

14

212.79 X 10

3

350-450

18

202.89 X 10-

-3

+ .002

-3

+ .001

-3

+ .001

A Coulter electronic counter was used to count and size the suspended epididymal
fat cells. Cell preparations were made only from rats weighing between 130-150
gms. The mean diameter of the fat cells in this weight range, obtained by
averaging the mean diameters from the individual cell suspensions used in the
various assays, came to approximately 44 + 0.4 u.
Micromoles free fatty acids/glycerol released per 10 6 target cells by 100 ug
of test material acting on rat epididymal adipose tissue fat cells equivalent to
1 gram of lipid in a medium of Krebs-Ringer phosphate buffer at 37°C for 1 hour ..

*

**

Mean + standard deviation of the combined group means.

1-'
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Frequency Distribution of Adipose Cell Diameters.
Mean diameter is representative of 985728 free
fat cells liberated by collagenase incubation
from epididymal fat pads of 130-150 gm rats.
Midpoint of classes and class limits and mean
cell diameter + standard deviation are shown.
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The mean cell dianeter + standard deviation of ~he co~bined
cell diameter frequency distributions came to 44 + 10

~·

The mean diameter + standard error of the mean of the
combined

freq~ency

distributions is 44 + 0.17

~.

Purification of FMS by Ultrafiltration
~ale

Thirty

albino rats of the Sprague-Dawley strain

were placed for 7 days on the high fat diet described previously.

Their urine was then collected under a 24 hour

fast at the cont~olled temnerature of 15°C.

The collected

urine was pooled, and crude FMS was extracted by the four
stage extraction process already described.
of crude

F~S

Preparations

were obtained from numerous urine collections

from a number of groups of animals.
After assaying, on an
crude

~~S

individ~al

basis, each lot of

obtained per 30 animals, all of the individual

preparations of crude

F~S

were pooled by dissolving them

in deionized water, and the solution was lyophilized.
The pooled crude FMS preparation was then divided into
multiple units, each unit being carried through the ultrafiltration proce0ure, but separately.

The results given in

Table 14 present the mean lipolytic activities for the
various fractions obtained from a number of these units that
were carried through each stage of ultrafiltration.
aqueous solution of crude

F~S

The

of each unit was first ouri-

fied by means of ultrafiltration using a PM-10 Diaflo
mer1brane.

The filtrate and the residue were each freeze-

Table 14
Purification of FMS by Ultrafiltration
Source

Amount
(mg)

Urine
Crude
FMS

Pt1-10
Filtrate

439

256

Material

Amount
(mg)

Lipolytic Activity*
FFA (umoles)***

Control

.361 + 0.03

Crude FMS

.454 + 0.01

P vs Source

Total Activity**
FFA (umoles)

-

P.H-10
Filtrate

271

.496 + 0.01

p

< 0.001

PM-10
Residue

156

.353 + 0.14

p

< 0.0025

55

UM-2
Filtrate

201

.326 + 0.02

p

< 0.001

66

54

.578 + 0.07

p

< 0.001

31

UM-2
Residue

-

-

134

* Expressed as umoles free fatty acids (FFA) released by 100 ug of test material
acting on 250 mg rat epididymal adipose tissue for 3 hours at 37oc.
** 'Total Activity', calculated as weight of extract (mg) times 'Lipolytic Activity'.
*** Mean + standard deviation, five determinations, with the exception of the
'Control' which is based on ten sets of five determinations.

,_.

1-'
~
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dried and bioassayed in vitro for lipolytic activity by
use of the assay utilizing the quantitative release of FFA
from e9ididymal fat pads.
The mean results of these analyses, show that the
active material was associated

wit~

the

P~-10

filtrate.

This filtrate in turn was ultrafiltered in the same manner
through a m-1-2 Diaflo membrane.

Both

t~e

filtrate and the

residue were again lyo9hilized and assayed in vitro for
lipolytic activity.

The activity \.Vas found to be associated

with the Uiv1-2 residue.

These findings are in agreement ;.,ri·th

those of Kwok, 1974.
Further ourification by ultrafiltration was
D~-5

ed by using a

accomplis~1-

Diaflo membrane which was substituted for

the UH-2 mer:ibrane in one inst:ance, and in another, incorporaJced into

t~e

9urificat.ion protocol (K\·lOk, 1974) afJcer

ultrafiltration by the

P~·1-10

and U!1-2 menbranes.

Fron the

results of these analyses shown in Table 15 it is apparent
that the active material
due under

bot~

~vas

associated tvith the D:-1:-5 resi-

of these ultrafiltration routes.

Crude FMS carried

tl1roug~1

the

U~-2

ultrafiltrative

yielded a product (UM-2 residue) with an increased in vitro
specific activity of about 27%

(Table 15).

Nhen

D~1-5

:.11 tra-

filtration was applied to this residue, the soecific activity of

t~1e

product (D!-1-5 residue) \vas about 60% greater

than that of crude FMS.

When UM-2 ultrafiltration was

omitt:ed and the P?1-10 fj_ltrate was subjec·ted directly to

TABLE 15
Purification of FMS by DM-5 Ultrafiltration
Source

Amount
(mg)

Material

Amount
(mg)

15

15

.496 + 0.01

DM-5
E'iltrate

11

.413 + 0.004

p

< 0. 001

4.5

.941 + 0.03

p

< 0.001

3.8

4

*

7.4

31

.578 + 0.07

UM-2
Residue
54

Total Activity**
FFA (umoles)

PM-10
Filtrate

m.1-5
Residue

UM-2
Residue

P vs Source

.361 + 0.03

Control

PM-10
Filtrate

Lipolytic Activity*
FFA (umoles)***

DM-5
Filtrate

10

.466 + 0.08

p

< 0.0125

DM-5
Residue

44

.728 + 0.01

p < 0.001

4.7
32

Expressed as umoles free fatty acids (FFA) released by 100 ug of test material
acting on 250 mg rat epididymal adipose tissue for 3 hours at 37°C.

** 'Total Activity', calculated as weight of extract (mg) times 'Lipolytic Activity'.
***Mean + standard deviation, five determinations, with the exception of the 'Control'-which is based on ten sets of five determinations.

1-'
1-'
0)
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DM-5 ultrafiltration, the specific activity of the product
(DM-5 residue) was about 107% greater than that of crude FMS.
This difference in percentage increase in specific
lipolytic activity per unit \veight of crude F.MS between
the two

D~-5

residues prepared via alternate routes of

ultrafiltration may be due to the increased time spent by
crude FMS in aqueous solution in the process of ultrafiltration, viz. a three step ultrafiltration procedure as
opposed to a two step ultrafiltration.

Beaton (1964) found

a significant loss of activity with FMS in aqueous solution
(pH 3.1) in a 24 hour period with no marked further loss
between 24 and 48 hours.
Another possible explanation is that an artifact in
the type of membrane used during ultrafiltration may cause
a structural change in the FMS fraction being ultrafiltered.
For example, DM-5 Series membranes are less hydrophilic
than UM membranes and have exceptional resistance to detergents, salts, and phosphates, which affect the UM structure.
Since the increase in time spent by FMS in aqueous solution
is relatively small when the ultrafiltration sequence includes the UM-2 ultrafiltration step, the latter possibilit¥
appears to be a more plausible explanation.
In making a comparison of the total activity data,
shown in Table 15, between the UM-2 residue and its products
of DM-5 ultrafiltration, it is noted that the total activity
of the UM-2 residue was 31 and of the products was 4.7
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(ultrafiltrate) and 32 (residue).

The sum of the total

activities of products (36.7) exceeds that of the original
UM-2 residue.

The same type of observation is noted in

Table 15 when comparing total activity data between the
PM-10 filtrate and its products of DM-5 ultrafiltration.
These discrepancies are not accounted for.

They may be due

to the removal of inhibitory substances or to the freeing
of active material from its bound form during the DM-5
ultrafiltration process.
Ultrafiltration via the DM-5 membrane added information as to the approximate molecular weight of FMS.

Al-

though ultrafiltration membranes do not yield quantitative
molecular weight fractionation, their rejection characteristics are suitable for separation of proteins into reasonably accurate molecular weight ranges.
In agreement with the work of Kwok (1974), fractionation of crude FMS into substances greater than and less
than 10,000 in molecular weight by PM-10 ultrafiltration
and subsequent bioassays indicated that the fraction with
molecular weight greater than 10,000 did not possess fatmobilizing activity,

(Table 14).

When the active fraction,

the PM-10 filtrate, was further fractionated in the same
manner through a UM-2 Diaflo membrane, with a cut-off at
1,000 in molecular weight, the active material was associated with the UM-2 residue.

Thus, active material isolated

from rat urine has a molecular weight between 1,000 to
10,000 daltons.
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The newly patented DM-5 Diaflo membrane has a cut-off
at 5,000 in molecular weight.

Fractionation of the PM-10

filtrate by DI1-5 ultrafiltration, followed by subsequent
in vitro bioassay indicated that the fraction with molecular weight greater than 5,000 (DH-5 residue) possessed the
fat-mobilizing activity (Table 15).
Fractionation of crude FMS first by PM-10 ultrafiltration followed by UM-2 ultrafiltration produced a substance
containing fat mobilizing activity with a molecular weight
between 1,000 to 10,000.

When this material with fat

mobilizing activity was then fractionated into substances
greater than and less than 5,000 in molecular weight by
use of the DM-5 Diaflo Bembrane, subsequent in vitro bioassay indicated that the fraction with molecular weight
greater than 5,000 (DM-5 residue) possessed the greatest
fat mobilizing activity per unit weight.

These data

approximate F.HS as isolated from rat urine to have a
molecular weight between 5,000 to 10,000 daltons.
Consideration of the results in Table 15 indicatethat
even though both routes of ultrafiltration via the DH-5
Diaflor membrane have indicated through subsequent in vitro
bioassay that the DM-5 residues possessed the fat mobilizing
activity, the DM-5 filtrate obtained from ultrafiltration
of the UM-2 residue, contained lipolytic activity similarin
degree to that of crude FMS.

In contrast, the inactive

fractions, namely, the PM-10 residue and the UM-2 filtrate
obtained from PM-10 and UM-2 ultrafiltration, possessed
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lipolytic activity of the same magnitude as that of the
control sample.

This suggests the possibility that the

FMS isolated from rat urine not only has a molecular weight
between 5,000 to 10,000, but that the molecular weight of
the substance containing fat mobilizing activity may be
close to 5,000.

Some of the fat mobilizing substance may

be leaking through the other side of the DM-5 Diaflomembrane, that has a cut-off of 5,000 in molecular weight,
during the ultrafiltration process.
Purification of FMS by Gel Filtration
Kekwick and Pawan (1967) reported the achievement of
some purification of FMS by passage of an ultrafiltrate,
derived from ultrafiltration with a Visking Dialysis membrane, through a column of Sephadex G-50 directly followed
by passage through a column of BioGel P-10, and pooling the
fractions which exhibited maximal U-V absorption.

When in

our laboratory, a 0.01% aqueous solution of UM-2 residue
was subjected to gel filtration employing these same two
gel types, in the same sequential arrangement, the elution
peak and the activity peak representing the transmittance
of the effluent at 280 nm were found to coincide with each
other (Kwok, 1974).
To date, there is no report of an elution profile,
data, or any descriptive information, on the purification
of FMS by gel filtration employing the exclusive use of
BioGel P-18 or Sephadex G-50.

Nor has an explanation
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or reason been given as to why the purification of FMS by
gel filtration necessitates passage of the source material
through these two functionally similar gel types.

Based

on the estimated molecular weight of FMS, both BieGel P-10
and Sephadex G-50 cover the same recommended fractionation
range desirable for optimum separation and/or purification
of FHS.
Consequently, consideration was given to the possibility of whether or not efficient gel chromatographic purification of FMS could be achieved with the elimination of one
of these chromatographic columns.
BieGel P-10 has an exclusion limit 10,000 less in
molecular weight than Sephadex G-50 and covers the approximate molecular weight range of 1,500 to 20,000 over which
separation of molecular substances, contained within the
UM-2 residue {1,000 to 10,000 in molecular weight), could
be expected to occur.

Therefore, initial column chroma-

tography was performed by passage of the UM-2 residue
through a prepared column of BieGel P-10 with elution by
deionized water.
The elution profile of the UM-2 residue on BieGel P-10
appears in Figure 7.

Fractions 6 to 9 and 20 to 23, corre-

sponding to elution Peak I and Peak II respectively, were
each pooled, lyophilized and assayed in vitro for lipolytic
activity by measuring the quantitative release of FFA from
rat epididymal fat pads.

As can be seen in Table 16 Peak I
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Top: Gel Filtration of UM-2 residue on Bio-Gel
P-10. Bottom: Gel Filtration on Sephadex G-50
followed by Bio-Gel P-10 of a combined preparation of Peak I and Peak II previously fractionated by passage of UM-2 residue through the column
of Bio-Gel P-10 (top). In both procedures, top
and bottom: column size 2.5 x 45 em; eluant deionized water; temperature 5°C; fraction size
5 ml. Percent transmittance monitored at 280 nm.
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TABLE 16
Purification of FMS by Gel Filtration

Material

BioGel P-10
Effluent

FFA, umoles*

Control

0.361 + 0.03

UM-2 Residue

0.578 + 0.07

UM-2 Residue

Peak I
Peak II

*

1.120 + 0.05** p < 0.001
.355 + 0.03

p < 0.001

0.835 + 0.02

DM-5 Residue***
DM-5 Residue

P vs. Source

Peak I

1.922 + 0.03

p < 0 001
0

Expressed as umoles free fatty acids (FFA) released by
100 ug of test material acting on 250 mg rat epididymal
adipose tissue for 3 hours at 37 degrees centigrade.

** Mean + standard deviation, five determinations.
***Composite mixture of the two DM-5 residues cited in
Table 15, 50% (w/w).
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contained lipolytic activity.

The second peak possessed

no lipolytic activity.
The in vitro specific lipolytic activity revealed
approximately two fold purification of the fat mobilizing
substance (FMS) contained within the UM-2 residue.

Purifi-

cation of crude FMS through gel filtration of UM-2 residue
on the BioGel P-10 column revealed a product whose specific
lipolytic activity had increased by 150%.
Gel filtration of the UM-2 residue through the prepared column of BieGel P-10 resulted in two major peaks,
only one of which, upon in vitro bioassay, contained lipid
mobilizing activity.

However, passage in our laboratory

(Kwok, 1974) of the same material (UM-2 residue) or passage
by Kekwick and Pawan (1967) of their material, of similar
fat mobilizing content (Visking Dialysis membrane, ultrafiltrate), through Sephadex G-50 and BieGel P-10 in sequential arrangement, demonstrated the elution of a single
major peak coinciding with the activity peak.

In an

attempt to provide more information concerning this difference between elution patterns, the following comparative gel chromatographic procedure was performed.
The remainder of the lyophilized material from Peak I
and the remainder of the lyophilized material from Peak II,
were recombined in equal proportions (w/w), and dissolved
in deionized water.

With deionized water as eluant, this
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aqueous mixture was subjected to gel filtration by passage
through a prepared column of Sephadex G-50, directly
followed by passage through the same BioGel P-10 column
employed in the previous UM-2 chromatographic procedure.
As can be seen in Figure 7, the elution profile contained
only one major peak.
This resultant difference between elution profiles on
UM-2 residue filtration via exclusive use of the BioGel P10 column and, upon recombination of the two UM-2 residue
eluant peak fractions from this BioGel column, the elution
profile on their refiltration via the sequential arrangement on Sephadex G-50 and BioGel P-10, does provide supportive evidence for better resolution of the component substances contained within the UM-2 residue.

This is demon-

strated by the two separate peaks on the UM-2 residue
BioGel P-10 elution profile, in contrast, to their resultant elution profile after their recombination and sequential refiltration through Sephadex G-50 directly followed
by BioGel P-10 which contains only one major peak.
The use of BioGel P-10 may provide better purification of the fat mobilizing substance contained within the
UM-2 residue than filtration through Sephadex G-50 directly
followed by BioGel P-10.

This purification improvement is

suggested by the appearance of two separate peaks on the
BioGel P-10 elution profile, of which only one contained
lipolytic activity.
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However, the disappearance of the second major peak from
the elution profile resulting from the sequentially
arranged columns may be due to the adsorption of this inactive substance, represented as the second peak (Fig. 7),
onto the Sephadex G-50 column before entrance of the effluent onto the BioGel P-10 column.

As a result, an insuffi-

cient quantity of this inactive component, if any, would be
available to produce a major peak upon its final elution
off of the sequentially following BioGel P-10 column.

The

same end would be accomplished; this being the removal of
this inactive substance from the UM-2 residue.
The possibility also exists, that this inactive substance cannot be dissociated from active FMS by gel filtration under the experimental conditions imposed by the sequential arrangement of the two gel types.

Interpretation

has been made subject to inherent limitation because, upon
completion of the sequential gel filtration procedure, an
insufficient quantity of material was available to provide
a quantitative bioassay.

However, upon attainment of the

experimental results on the DM-5 residue gel filtration
procedure next to be described, further pursuit of the sequential filtration procedure was not an utmost necessity.
Beaton et al.

(l966b) upon fractionation of their

ultrafiltrate derived from ultrafiltration under a Visking
cellulose tubing {pore size 24

R)

on Seohadex G-25 {frac-

tionation range 1,000 to 5,000 in molecular weight), demon-
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strated the presence of three active fractions associated
with the ultrafiltrate.

In our laboratory Kwok (1974)

passed an aqueous solution of UM-2 residue through a
Sephadex G-25 column with elution by distilled water and
found the activity to be associated only with the first
ten 5 ml fractions.
The results obtained by our laboratory (Kwok, 1974)
suggested that the lipolytically active material may be
approximately equal to, or greater than 5,000 in molecular
weight.

Further evidence was provided in support of this

hypothesis, when after DM-5 ultrafiltration (cut-off 5,000
in molecular weight) of the PM-10 filtrate or the UM-2
residue, the lipid mobilizing substance was found to be
primarily contained within the DM-5 residue.
As a consequence of these experimental findings, this
DM-5 residue was subjected to further purification by gel
filtration, with elution by deionized water, using the BioGel P-10 column.

The elution pattern of the DM-5 residue

on BioGel P-10 appears in Fig. 8.
Fractions 19 through 22, corresponding to the elution
peak were pooled, lyophilized, and the residue assayed in
vitro for lipolytic activity by measurement of the quantitative release of FFA from rat epididymal fat pads.

As can

be seen in Table 16, there is a significant difference in
lipolytic activity between the DM-5 residue and the substance of the elution peak (p < 0.001).

In vitro specific
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Gel Filtration of DM-5 Residue on Bio-Gel P-10.
Column-size 2.5 x 45 em; eluant deionized water;
temperature 5°C; flow rate 1.8 ml/minute; fraction size, 5 ml. Percent transmittance monitored
at 280 nm.
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lipolytic activity increased 130% per unit weight of the
composite DM-5 residues obtained via DM-5 ultrafiltration.
The extension of the purification process to include
molecular sieve chromatography exclusively via BioGel P-10
with the elimination of Sephadex G-50, enhanced the specific
lipolytic activity of crude FMS on a weight-for-weight
basis by 147% for the UM-2 residue and 323% for the DH-5
residue.
Isoelectric Focusing of FMS
FMS at various stages of its purification was subjected to isoelectric focusing.

Fig. 9 depicts the UV absorp-

tion curve and superimposed pH curve obtained by eluting
and subsequent monitoring of the electrofocused FMS Fraction
I, FMS Fraction II, and FMS Fraction III bands and an unnamed band associated with FHS Fraction III from the electrofocusing apparatus in which the FMS UM-2 residue preparation has been resolved.
hours.

The electrofocusing run required48

The pH of the collected fraction at the elution

peaks corresponds to the pi of the various resolved FMS
Fractions.

The electrofocusing was run at 4°C.

The pH

readings were determined at 4°C.
Fig. 10 depicts the electrofocused FMS Fraction I and
FMS Fraction II bands from the apparatus in which the FMS
DM-5 residue preparation has been resolved.
Fig. 11 shows resolution of the FMS Fraction I andFMS
Fraction III bands from the active eluant peak fractions
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obtained from passage of FMS UM-2 residue through a Sephadex G-50 BieGel P-10 column.

FMS Fraction III is directly

followed by three unidentified bands corresponding to the
pi of 5.3, 5.4, and to the pi of 6.1.

These bands present

though not shown on the UM-2 residue electrofocusing map
(Fig. 9) proved to be non-active lipolytically.
No matter which FMS preparation is resolved, the highly
sensitive resolving power of the isoelectric focusing technique clearly demonstrates that the FMS Fractions (lipolytically active bands) will always end up at the point in
the gradient where the pH is equal to the isoelectric point
of the protein component.
In Vitro Bioassay of FMS Fraction I, FMS Fraction II and FMS
Fraction III
All electrofocused bands eluted from the electrofocusing column were initially assayed in vitro for lipolytic
activity by the very rapid and simple modified method of
Duncombe (1964).

One hundred micrograms of test material

was incubated with 250 milligrams of rat epididymal fat pad
in a medium of Krebs-Ringer phosphate buffer containing 4
per cent bovine serum albumin.
Table 17 shows the results for the initial bioassay of
FMS Fractions I, II, III, and unidentified bands.

For com-

parative purposes, the results are expressed in terms of
umoles FFA released per gram of epididymal fat pad upon incu-
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TABLE 17
Lipolytic Activity of Electrofocused Bands from the
Electrofocusing Column in which FMS Preparations
Have Been Resolved

Material

No. of
Determinations

In Vitro*
Lipolytic Activity

Control

15

1.44 + .12**

FMS Fraction I

15

7.24 + .38

FMS Fraction II

10

7.29 + .26

FMS Fraction III

5

7.14 + .54

Unidentified Bands
(Include those of:
pi 5.3, 5.4 and 6.1)

5

1.43 + .37

*

Expressed as umoles free fatty acids released by 100
ug of test material acting on 1 gram of rat epidicymal
adipose tissue from 3 hours at 37°C.

**

Mean + standard deviation, five determinations, composite of data obtained from lipolytic assays of the fractions from the three electrofocusing profiles.
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bation for 3 hours at 37oc being acted upon by 100 micrograms of test material.

It is observed that there is no

difference in lipolytic activity between FMS Fraction I, II
and III.
FMS Fractions I, II, and III were further subjected to
in vitro bioassay utilizing the more specific assay system
which employs isolated fat cells for direct analysis on target cell-FMS interaction.

Table 18 expresses in terms of

FFA release the lipolytic response of FMS target cells to
100 micrograms of FMS Fraction I, FMS Fraction II, and FMS
Fraction III on a per unit cell lipid basis.
The lipolytic activity of each of the three FMS fractions was significantly different from that of crude FMS
(p < 0.001}.

The lipolytic activity of the crude FMS was

significantly different from that of the Controls (p
0.05).

<

Analysis of variance (F-test) on FMS Fraction I,

II, and III shows that on a per unit cell-lipid basis the
lipolytic activity does not differ significantly amongst the
three fractions of FMS (p > 0.2).
Table 19 expresses on a per unit cell-lipid basjs the
lipolytic response of FMS target cells to 100

~icrograms

of

FMS Fraction I, FMS Fraction II, and FMS Fraction III in
terms of glycerol release.

Whereas net changes in the

amount of free fatty acids released into the incubation
medium represent the difference between the amount formed

...

-

by lipolysis and the amount reesterified, glycerol is a more
probable reflection of the rate of lipolysis.

The correla-
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TABLE 18
FFA Release as Index of Lipolytic Activity of FMS
at the Initial and Final Stages of Purification

FHS
Control

No. of
Determinations
6

In Vitro*
LipoT:Yt1c Activity
10.3 + 0.55**

15

11.0 + 0.60

Fraction It

5

31.2 + 0.71

Fraction II

5

31.8 + 0.56

Fraction III

5

31.3 + 0.74

Crude Fr'iS***

* Expressed as umoles free fatty acids released by 100
ug of test material acting on rat epididymal adipose
tissue fat cell suspension equivalent to 1 gram of
lipid for 3 hours at 37°C.
** Mean + standard deviation, for the given number of
determination?.
*** Composite of FMS extracted from each of the three
weight-age categories.

t Composite fractions from three isoelectric focusing
profiles.
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TABLE 19
Glycerol Release as Index of Lipolytic Activity of
FMS at the Initial and Final Stages of Purification

FMS***
Control

No. of
Determinations
6

In Vitro*
Lipolytic Activity
1.16 + 0.00**

10

2.18 + 0.16

Fraction I

5

9.41 + 0.03

Fraction II

5

9.35 + 0.07

Fraction III

5

9.36 + 0.01

Crude FI-1S

*

Expressed as umoles of glycerol released by 100 ug
of test material acting on rat epididymal adipose
tissue fat cell suspension equivalent to 1 gram of
lipid for 3 hours at 37oc.

** Mean + standard deviation, for the given number of
determinations.
***FMS material as described in Table 18.
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tion between the rate of lipolysis on each of the three
FMS Fractions for these two criteria of lipolytic activity
is significantly positive, showing no reesterification is
taking place.
Adipose tissue cellularity was determined on every
fat cell suspension prepared for bioassay by the use of the
Coulter electronic counter.

Table 20 expresses in terms of

glycerol and FFA release per 10

6

target cells, the lipoly-

tic activity of FMS Fraction I, II and III.
Determination of Total Protein Content of FMS Fraction I,
FMS Fraction II, and FMS Fraction III
The protein content of the three FMS Fractions \vere
measured using the method of LO\'lry et al.

(1951).

Table

21 displays the data obtained for these analyses.
Specific lipolytic activities for FMS Fraction I,
FMS Fraction II, and FHS Fraction III, in terms of umoles
of FFA or glycerol released per 100 ug of FMS protein
acting upon rat epididymal adipose tissue cell suspension
for 3 hours at 37°C, are given in Table 22.

For both

indexes of lipolytic activity, FMS Fraction I and FMS Fraction II contain the greatest degree in vitro specific lipolytic activity.
Polyacrylamide Gel Electrophoresis of FMS
FMS Fraction I, FMS Fraction II, and FMS Fraction "III"
(Fraction III plus pi 4.8 band) were examined for homogene-

TABLE 20
Response of Adipocytes to FMS at the Initial
and Final Stages of Purification

FMS**

No. of
Determinations

Control

6

Crude

Fraction II
Fraction III

Glycerol
6
(umoles/10 cells/hr)*
200.76 X 10- 3 + 0.01*** 31.26 X 10- 3 + 0.000***

-

-3

-3 + 0.003

5

609.77 X

-+ 0.01
10- 3 + 0.01

183.91 X 10- 3 + 0.001

5

621.89 X 10 -3 + 0.01

182.74 X 10- 3 + 0.001

15

Fraction I

FFA

5

215.08 X 10

611.73 X 10

-

-3

+ 0.01

-

42.33 X 10

182.93 X 10- 3 + 0.000

A Coulter electronic counter was used to count and size the suspended epididymal fat cells. Cell preparations were made only from rats weighing between
130-150 gms. The mean diameter of the fat cells in this weight range, obtained by averaging the mean diameter from the separate cell suspensions used in
the various assays, came to approximately 44u.
6
* Micromoles of free fatty acids or glycerol released per 10 target cells by
100 ug of test material acting on rat epididymal adipose tissue fat cells
equivalent to, l gram of lipid in a medium of Krebs-Ringer phosphate buffer at
37°c for '1 hr.

·'

** FMS material

~s

described in Table 18.

*** Mean + standard deviation.
I-'

w

~'
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TABLE 21
Total Protein Content of
FMS ?ractions I, II and III

FMS

Number of Determinations

Percent
Protein*

Fraction I

5

59 + 5

Fraction II

5

60 + 6

Fracti·on III

5

100 + 2

* Mean + standard deviation.
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TABLE 22
Specific Lipolytic Activity of FMS Fraction I,
FMS Fraction II, and FMS Fraction III Protein

FHS

Deteminations

FFA*
(umoles)

Glycerol*
(U.L1loles)

Fraction I

5

52.88 + 0.71** 15.95 + 0.03**

Fraction II

5

53.03 + 0.56

15.58 + 0.07

Fraction II

5

31.30 + 0.74

9.36 + 0.01

*

Expressed as umoles FFA or glycerol released by 100 ug
of FMS protein acting on rat epididymal adipose tissue
cell suspension equivalent to 1 gram of lipid for 3 hours
at .37°c.

** Mean + standard deviation, five determinations.
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ity by polyacrylamide gel electrophoresis.
photographically shown in Figure 12 and 13.

The results are
Figure 12 re-

presents analysis with 250 micrograms of sample per gel.
Figure 13 displays the 150 microgram sample gels of FMS
Fraction I, II, and

11

III 11 whose staining intensities were

subjected to quantitative densitometry with the Densicord
Model 542 densitometer in conjunction with a Keuffel and
Esser Model 620005 compensating polar planimeter.
FMS Fraction I and FMS Fraction II separated into one
major and one minor band.

FMS Fraction

11

III 11 separated

into two major and five minor bands.
Figure 14, 15, and 16, show respectively, densitometer
scans of FMS Fraction I, FMS Fraction II, and FMS Fraction
"III 11 150 microgram sample gels.

The 250 microgram sample

gels were not subjected to quantitative densitometry due to
broadened bands (overloaded bands) that distorted the pattern on the densitometer tracing.
The FMS Fraction I electrophoresed gel's slowest moving
component, Component I, contained 97% of the total staining
intensity, while Component II contained the remaining 3%
(Figure 14).

Identical quantitative staining intensity

values were computed for the major and slmvest-moving band,
Component I, and the minor band, Component II, present in
the FMS Fraction II electrophoresed gel (Figure 15).
The staining profile on the FMS Fraction "III 11 electrophoresed gel revealed that two bands, Component II {40%)
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Figure 12:

Polyacrylamide Gel Electrophoretic Patterns
of (A) FMS Fraction II, (B) FMS Fraction III,
and (C) FMS Fraction I, with 250 ug FMS Sample Application. Detection with fixativedye 20% TCA-Coomassie Brilliant Blue stain
solution.

-

-·
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Figure 13.

8

Polyacrylamide Gel Electrophoretic Patterns
of (A) FMS Fraction II, (B) FMS Fraction III,
and (C) FMS Fraction I, with 150 ug FMS Sample Application. Detection with fixative-dye
20% TCA-Coomassie Brilliant Blue stain solution.
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Chart Record of Percent Transmittance from Densicord Model 542
Densitometer Scan of FMS Fraction I Electrophoresed Gel after
Staining with Coomassie Blue. Quantitation revealed that component I accounted for 97% of the staining profile and component II 3%.
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Chart Record of Percent Transmittance from Densicord Model 542
Densitometer Scan of FMS Fraction II Electrophoresed Gel after
Staining with Coomassie Blue. Quantitation revealed that component I accounted for 97% of the staining profile and component II 3%.
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Chart Record of Percent Transmittance from Densicord Model
542 Densitometer Scan of FMS Fraction "III" Electrophoresed
Gel After Staining with Coomassie Blue. Quantitation revealed that component II (40%) and component V (36.7%) account
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and V (36.7%), accounted for over three-fourths of the total
staining intensity.
the remaining 23.3%:

The various minor bands accounted for
Component I, 0.6%; Component III, 4.4%;

Component IV, 8.3%; Component VI, 8.5%; and Component VII,
1.5%.
The tracking dye band of Coomassie blue was allowed to
migrate to a predetermined mark shown 75 em from the origin
respective to the chart recording, to allow mobility measurement comparison, upon alignment of the series of gels.
Approximately the same distance of migration is observed for
the one major and one minor band (FMS doublet) of FMS Fraction I and II upon gel electrophoresis.

CHAPTER IV
DISCUSSION AND CONCLUSIONS
A Fat Mobilizing Substance (FMS) shown to accelerate
lipolysis of triglyceride in adipose tissue has_been isolated from the urine of various mammalian species, including man, during fasting and in other conditions associated
with increased catabolism of fats (Chalmers et al., 1958,
1960; Stevenson et al., 1964; Beaton et al., 1966; Pawan,
1971}.
FMS appears to be a polypeptide and is presumed to act
by stimulating adenylate cyclase (Kwok, 1974).

The precise

chemical nature of this substance is not known, and to date,
none of its physical characteristics have been reported.
Progress in this area has been hampered by the fact that
only milligram quantities have been obtained by current
purification procedures, resulting in a lack of ready availability of purified material suitable for basic work.
Numerous studies have shown that a loss of body fat
results from a decrease in the size of adipose tissue cells.
Injected FMS causes a mobilization and reduction of the body
fat content (Chalmers et al., 1960; Kekwick and Pawan, 1968);
hence, a reduction in the size of these fat cells.
Urinary FMS is a reflection of the production of this
substance in the body and its excretion by the kidneys.
149
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Observations of higher mean urinary FMS levels in a group
of non-obese as compared with the mean values in obese subjects (Pawan, 1971) and that infant and young children excreted more fat mobilizing activity then did young male
adults during an 18 or 24 hour fast (Stevenson et al., 1965),
together with the knowledge that adipose tissue relative to
body weight increases with age and is markedly increased in
the obese condition, suggest that FMS may be part of a physiological homeostatic control of body fat with weight and
age possibly bearing a relationship to the degree of FMS
production and secretion.
Accordingly, this study was concerned with obtaining
further information relevant to the characterization of
this lipolytic factor.

The focus was directed to (1) de-

velopment of an assay system based on FMS-target cell interaction from fat cells of known size and lipid content,

(2)

introduction of a glycerol in vitro bioassay procedure as
an index affording comparative criterion to the existing
in vitro measurement of FFA release for the lipolytic
response of FMS,

(3) direction of attention towards the

degree in which age and weight factors affect the quantity
and quality of FMS urinary excretion, and (4) improvement
of the efficiency of purification of this active principle.
In the first part of this study, crude FMS was isolated
according to the time-honored method involving benzoic acid
precipitation of FMS from the urine of fasting rats, water
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extraction, alcoholic precipitation, and lyophilization of
the precipitate after redissolving in distilled water.
Initially the colorimetric method developed by Duncombe
(1964), as modified by Kwok (1974), was applied to determine
the quantitative release of FFA from epididymal fat pads of
the rat into the medium.

This proved to be the most rapid

and convenient method.
Accurate comparative interpretation to previous works
which express FMS lipolytic activity data in terms of
release of FFA per 250 milligram rat epididymal fat pad
being acted upon by 100 miprograms of FMS, rests upon the
conditional state of the epididymal fat pads utilized within
the assay system.

Previous studies in our laboratory (Kwok,

1974) utilized fasted rats which predisposes the tissue to
a higher initial concentration of FFA.

In this study, how-

ever tissue fragments were excised from epididymal fat pads
of normal fed rats; hence a reasonable explanation, for the
relatively higher control values in former studies of Kwok
(1974) in comparison to those obtained in this study.

The

amount of FFA released into the medium is greater from adipose tissue fragments excised from epididymal fat pads of
fasted rats than from adipose tissue of normal fed rats.
Although control lipolytic activity values were different
in degree for each adipose tissue conditional state, the
activity ratio of control/crude FMS was the same.
Beaton et al.,

Moreove4

(1966a) applying the same experimentaldesign
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and mode of data expression and utilizing epididymal fat
pads from normal fed rats, obtained similar values on
control and crude FMS data to those obtained in this study.
The increased sensitivity of isolated fat cells to
lipolytic agents was demonstrated in this study by applying
an assay system utilizing isolated fat cells to measure the
lipolytic response of FMS.

In addition, this method of

assay provided an opportunity to study the lipolytic activity of FMS as a function of cell size, number and known
lipid content.

The Coulter electronic counter reliably

measured the number of cells and provided the means to
obtain the volume and diameter of the target cells.
Thought was given to the cellular nature of the adipose tissue to be employed within the assay systems, since
it has become increasingly evident that differences in
adipose tissue mass due to the number of the adipose cells
in the tissue and the size of these adipocytes can have an
effect on the metabolic activity of this tissue.
Fat cell size in the rat increases throughout growth.
Fat cells may lose their sensitivity to the lipolytic
effects of FMS as they enlarge.

In applying this

~oncept

to the in vitro systems used in the various approaches to
assay FMS, older rats of increased weight would have larger
fat cells, which could be less sensitive to the lipolytic
effects of FMS than the smaller fat cells from younger rats
lesser in weight.

Consequently, cell preparations were
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made only from rats weighing between 130-150 grams.
This study showed that the individually prepared cell
suspensions obtained from each rat in. this particular
weight range display a marked degree of intra-suspension
heterogeneity, in adipocyte diameter and volume.

Also

displayed, was their marked degree in diameter and volume
inter-suspension homogeneity.

The mean cell diameter for

any one cell suspension never deviated an entire micron
from the experimentally determined mean of means cell diameter of 44 u, with predictable, similar cell frequency
distributions procured on all the independently prepared
cell suspensions derived from different rat stock within
this 130-150 gram weight range.

Values on mean cell dia-

meter and volume determined within this study are in
essential agreement with data published by other groups
e.g., Livingston et al., 1974.

Within this particular

weight range the rat maintains a reliable and reproducible
mean cell diameter and cell volume.
Normal fed rats of the same weight range (130-150
grams) were utilized in each and every approach employed in
the testing of the various FMS preparations.

Therefore,

comparisons could be made between the cellular responsiveness of intact epididymal adipose tissue and that of isolated fat cell suspensions to the lipolytic action of FMS.
A sizeable increase in lipolytic activity was observed in
all assays utilizing isolated fat cells significantly above
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the activities obtained with the bioassays employing intact
epididymal fat pads.
In addition, to the quantitative release of FFA by
FMS-target cells, the establishment in this study of glycerol release as a reliable index of FMS lipolysis was
initiated not only to remove the inherent problem of relying on only one criterion for in vitro measurement of FMS
lipolytic activity, but to make it possible to draw certain
inferences concerning changes in the rate of lipolysis and/
or reesterification.

During lipolysis, glycerol is re-

leased and not metabolized to any significant extent.

The

free fatty acids can be activated and reesterified (Vaughan,
1962).

The relationship existing between the data obtained

on these two parameters of lipolytic activity, shows no
reesterification of the free fatty acid had taken place
during FMS induced lipolysis in any of the in vitro bioassays performed for the testing of FMS lipolytic activity.
Also, it can be affirmed that the glycerol released into
the medium was produced from triglycerides and not by
hydrolysis of a-glycerophosphate or

fro~

smaller glycerides.

Glycerol produced by hydrolysis of a-glycerophosphate or
from lower glycerides would be associated with the formation of only 0 to 2 umoles of FFA per umole glycerol,
instead of the 3 umoles per umole of glycerol produced
from triglycerides observed in this study.
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When the lipolytic activity elicited by FMS isolated
from groups of male rats of variable weight and age was
studied, it was found that an increase in weight and age
was accompanied by a concomitant decrease in FMS specific
activity and an increase in total activity.

The lipolytic

response of isolated adipocytes measured by their quantitative release of FFA and glycerol was found to display
a highly positive correlation to the release of FFA by
epididymal fat pads in response to the lipolytic action of
FMS.
On the basis of FFA released per 250 milligram epididymal fat pad being acted upon for 3 hours at 37°C, a
direct comparison to the results of Beaton et al.
could be made.

(1966)

In essential agreement with Beaton, the

greatest specific lipolytic activity was found in FMS isolated from male rats weighing between 150-250 grams \'lith a
mean age of 7 weeks.

Beaton, in observing the specific

activity excreted by 24 male rats at five different age
intervals as they increased in age from 26 to 78 days,
found that the greatest specific activity was excreted at
50 days of age, 147 grams.
In contrast to Beaton et al.

(1966), total lipolytic

activity was found to increase with increasing weight and
age.

For male rats weighing between 350-450 grams with a

mean age of 18 weeks, the total activity nearly doubled
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that excreted by male rats weighing between 150-250 grams
at a mean age of 7 weeks.
Beaton (1966) reported the greatest total lipolytic
activity to be at 37 days of age (102 grams) with a nonappreciable variance between 37, 50 and 62 days of age
(102, 147, 197 grams).

FMS excretion decreased markedly

between 62 and 78 days of age (297 grams).
A plausible explanation does exist for this significant difference in total activity data between Beaton
and the experimental findings of this thesis.

This differ-

ence may be. the consequence of a difference in experimental
protocol applied by Beaton et al.
our laboratory.

(1966) and that used in

Beaton fasted 24 male rats at 26 days of

age and subjected this

Sru~e

group of animals to the fast

at 37, 50, 62, and 78 days of age.

He employed neither a

high fat diet nor a fast under cold stress as was applied
in this experiment.

In this current study, 11 different

rat groups of 30 each were used to investigate the effects
of weight and age on FMS excretion.
More importantly, the current experimental protocol
eliminated the recycling of the same test animals.

In

contrast to 11 different groups of rats being subjected to
fast under cold stress on a one time basis, Beaton subjected one groups of rats repeatedly to a fast at different
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age intervals; this may have led to an exhaustion of the FMS
supply available, or to a defect in FMS production in these
animals.
This possible explanation can be substantiated with
use of other data published by Beaton et al.
same report.

(1966) in the

When Beaton tested the effect of duration of

fasting on excretion of FMS by the rat, he found a high
total activity for rats weighing 270 grams during a 24 hour
fast, when the rats were used on a one time basis; in contrast, he found a low total activity in rats 78 days in age
(mean weight 297 grams) and fasted for 24 hours, rats that
were repeatedly subjected·to this experimental
Further, Beaton et al.

condition~

(1966) in a study of ·the effect of

the sex of the animal on FMS excretion showed a high total
activity for male rats 90 days of age (mean weight 329
grams), higher than any total activity reported at any age
for the repeatedly used rats in his study of age effects on
FMS excretion.
Because of the small quantities of starting material
available, each step in the attempted procedures for purification was assessed to determine the most suitable combination of extraction, ultrafiltration, and gel filtration
for the isolation of purer material.
Some purification can be achieved by Diaflo ultrafiltration.

The products of DM-5 ultrafiltration appear

to

produce retentates of higher specific activity and products
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of higher yield in total activity than the preceding ultrafiltration products of either PM-10 or UM-2 ultrafiltration.
Also there are decreased losses in total activity when the
DM-5 ultrafiltration is directly preceded by PM-10 ultrafiltration as opposed to DM-5 ultrafiltration preceded by
UM-2 ultrafiltration of the PM-10 filtrate.

Consequently,

it appears profitable to incorporate DM-5 ultrafiltration
into existing FMS ultrafiltration purification protocol
with the possible elimination of the UM-2 ultrafiltration
step.
Although Kekwick and Pawan (1967) and in our laboratory,
Kwok (1974), have achieved further purification of their
respective active ultrafiltration products by gel filtration through a column Sephadex G-50 directly followed by
BioGel P-10, passage through both of these two functionally
similar gel types appears not to be of necessity when the
DM-5 residue is being further purified.

It seems that DM-5

ultrafiltration removes the same inactive material, contained in the UM-2 residue and in the PM-10 filtrate, as
does the Sephadex G-50 chromatographic column.

This,

suggests elimination of Sephadex G-50 gel filtration from
the existing FMS purification protocol in dealing with the
further purification of the DM-5 residue.
It can be further deduced, that passage through both
Sephadex G-50 and BioGel P-10 gel chromatography

col~~s

may not be essential for further UM-2 residue purification

159
by gel filtration.
into~an

With the separation of the UM-2 residue

active and inactive peak fraction upon gel filtra-

tion by exclusive use of BieGel P-10, preparation of a
Sephadex G-50 column to remove the same inactive material
should be unnecessary.
Relative to the DM-5 residue, a relatively small amount
of,activity was present in the DM-5 filtrate.

It now

appears that the source of this activity is FMS Fraction III
isolated from the isoelectric analysis of the UM-2 residue.
FHS Fraction III in combination with non-lipolytic material
is contained within the PM-10 filtrate and UM-2 residue but
is removed by DM-5 ultrafiltration; and, as a consequence,
appears to be found in the DM-5 filtrate.

As shown on the

UM-2 residue electrofocusing map, FMS Fraction III as contained in the UM-2 residue is closely associated with nonlipolytic material which could not be removed from FMS
Fraction III when the UH-2 residue was directly subjected
to isoelectric focusing without being previously purified
by gel filtration.
This inactive material along with FMS Fraction III is
removed upon DM-5 ultrafiltration of either the PM-10 filtrate or UM-2 residue.

Consequently, this inactive materi-

al, as well as FMS Fraction III, are still contained within
the DM-5 filtrate.

This seems in part to logically account

for the relatively low specific lipolytic activity associated with the DM-5 filtrate.
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The ease and convenience of DM-5 ultrafiltration in
comparison to preparation of the Sephadex G-50 chromategraphic column, coupled with DM-5 ultrafiltration higher
specific and total activity yields than PM-10 or UM-2
ultrafiltration, suggest that DM-5 ultrafiltration of the
PM-10 filtrate followed by gel filtration on BioGel P-10 to
be'the most suitable combination of ultrafiltration and gel
filtration for future purification of FMS Fraction I and
FMS Fraction II.
FMS Fraction III contained within the DM-5 filtrate,
following DM-5 ultrafiltration of the PM-10 filtrate, must
be further purified by either BioGel P-10 or Sephadex G-50
before being subjected to electrofocusing under the current
experimental protocol employed for isoelectric analysis.
To obtain purified FMS Fraction III BioGel P-10 filtration
would be the method of choice if no electrofocusing were to
be carried out.

Consequently, first, the DH-5 residue would

be applied to the BioGel P-10 column, then, the DM-5 filtrate would be applied following the elution of FMS Fraction I and FMS Fraction II.

As experimentally shmvn, the

DM-5 residue \'ITOuld produce one major elution peak containing both FMS Fraction I and F.HS Fraction II.

In agreement

with the UM-2 residue BioGel P-10 filtration, the DM-5
filtrate would produce one activity peak (Fraction III) and
an inactive peak fraction.
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A limitation of ultrafiltration and gel filtration in
the isolation and purification of FMS is the inability of
gel filtration to separate FMS Fraction I from FMS Fraction
II.

Their isolation can be achieved by isoelectric focus-

ing of the DM-5 residue without prior gel filtration.

Gel

filtration may become obsolete for isolation of FMS Fraction
III if a narrower ampholine range is used during isoelectric analysis of the DM-5 filtrate.
Obviously, ultimate proof of the best applicable
purification route, rests in determination of FMS amino
acid sequence, synthesis of a peptide with the proposed
structure, and demonstration that the synthetic material
has the full biological potency ascribed to FMS.
In addition to serving as techniques for further
purification of crude FMS, ultrafiltration and isoelectric
focusing added to existing information on the approximate
molec.ular weight of FMS.

In agreement with Kwok (1974),

UM-2 ultrafiltration of the PM-10 filtrate yielded a substance containing fat mobilizing activity with a molecular
weight between 1,000 to 10,000 daltons.

When this fat-

mobilizing material was further fractionated into substances
greater than and less than 5,000 in molecular weight by use
of the Diaflo ultrafiltration apparatus fitted with the
newly patented DM-5 Diaflo membrane, subsequent, in vitro
bioassay, revealed that the fraction with molecular weight
greater than 5,000 possessed the greater fat mobilzing
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activity.

In accordance with the subsequent isolation of

FMS Fraction I and FMS Fraction II upon resolution of the
DM-5 residue on the electrofocusing ap9aratus, FHS Fraction
I and FMS Fraction II, have to be between 5,000 and 10,000
in molecular weight.
Although :!"elative to the DM-5 residue, the 0::1-5 filtr~te contained negligible lipolytic activity, it did con-

tain lipolytic activity similar in degree to that of crude
FMS, thus indicating the presence of a lipolytically active
fraction with a molecular weight between 1,000 and 5,000.
In conjunction with the cumulative data obtained from
the separate electrofocusing of DM-5 and the UM-2 residues,
it appears that FMS Fraction III is contained within

t~e

DM-5 filtrate and has a QOlecular weight between 1,000 to
5,000.

Furthermore, present data, along with previous work

done by other researchers and in our laboratory (Kt.;ok, 1974)
seem to justify the conclusion that FMS Fraction III
appears to be a dis-tinctive polype?tide of molecular weight
to the upper range of an estimate a= 1,000 to 5,000 daltons.
For example, in our laboratory K'tTOk,

(1974) upon fractiona-

tion of UM-2 residue through Sephadex G-25, molecular weight
range between 1,000 and 5,000, found the activity to be
associated

wit~

and initially after the void volume of the

column.
Isoelectric focusing, proved important as a separation
technique in the isolation and further purification of FMS.
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The lipolytically active principle as resolved on the electrofocusing apparatus showed three active variants, namely:
FMS Fraction I, FMS Fraction II, and FMS Fraction III.
structural difference between these

~hree

The

FMS fractions that

account for their resolution during electrofocusing were not
established.
As in other polypeptide hormones, the biological and
immunological activities may reside in structural sub-entities that may be similar but may also differ in important
structural details not yet clarified.

Many highly purified

proteins produce multiple bands, because of the presence of
conformational isomers, isozymes, or partially filled sites
for the essentially irreversible binding of metals, coenzymes
and other small molecules.

Such mechanisms may account for

the microheterogeneity of FMS shown in the isoelectric
separation of FMS Fraction I and FMS Fraction II.
FMS Fraction I and FMS Fraction II are resolved on the
electrofocusing apparatus as two distinct FMS variants, but
are eluted as one major activity peak upon DM-5 or UM-2
residue gel filtration on BioGel P-10 and upon UM-2 residue
gel filtration on Sephadex G-50 directly followed by BioGel
P-10.

In addition, FMS Fraction I, and FMS Fraction II,

are in the same, comparatively constricted, molecular weight
range set by their identical fractionation properties upon
ultrafiltration, display a non-significant difference in
specific lipolytic activity and showed the same protein
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content upon analysis.

Furthermore, FMS I and FHS II

displayed identical staining properties upon examination
by gel electrophoresis.
With respect to FMS Fraction III, the heterogeneity
of FMS shown on the electrofocusing apparatus may reflect
some change incurred prior to excretion or generated during the isolation and purification of FMS.

It might be

argued that FMS Fraction III is identical to the first and
second FNS Fractions with the non-protein component of FMS
Fraction I and FMS Fraction II being removed from FMS Fraction III.

The hypothesis is supported by the results of

protein analysis of the fractions.
Electrofocusing yielded some data towards the estimation of the isoelectric point (pi) of FMS Fraction I, II,
and III.
The pi (isoelectric point) values corresponding to
FMS Fraction I and FMS Fraction II were respectively, pi
4.1 and pi 4.5, in the preparative separation of DM-5
residue or UM-2 residue.
FMS Fraction III yielded a pi value of 5.1 in the
resolution of UM-2 residue and of the active eluant peak
fractions obtained from passage of FMS UM-2 residue through
a Sephadex G-50-BioGel P-10 column.
Upon analysis of the three FMS fractions by polyacrylamide gel electrophoresis and densitometric quantitation,
no difference was detected between FMS Fraction I and FMS

Fraction II electrophoresed gels.

165
The combination of the

electrophoretic and molecular filtration effects resolved
both FMS Fraction I and II into two discrete bands.

FMS

Fraction I contained one major and one small fast moving
subsidiary band.

This same doublet was also contained in

FMS Fraction II.

The two discrete bands exhibited identical

staining intensity values and identical migration distances.
A third active FMS fraction resolved in the isoelectric
analysis of UM-2 residue was subjected to PAGE.

As shown

on the UM-2 residue electrofocusing map (Figure 9), FMS
Fraction III, pi 5.1, and an inactive fraction, pi 4.8,
comprise FMS Fraction "III".

The degree of heterogeneity

is unaccounted for.
In favorable agreement with the results in this experiment on PAGE, Kekwick and Pawan reported obtaining one
major component peak, in the ultracentrifuge, with a small
subsidary peak in testing the homogeneity of their partially
purified FMS extract.
when subjected to PAGE.

This same extract gave a single band
With reason, this single band

migration on the polyacrylamide gels can be made subject
to debate since the experimental conditions associated with
their PAGE were not defined.

The relative position, sharp-

ness, and intensity of minor bands can be easily affected
by changes or differences in the conditions of PAGE:

pH,

buffer composition, ratio of acrylamide monomer to bisacrylamide, etc.
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In contrast to the results on PAGE analysis of FMS
found in this study, Kwok (1974}, in our laboratory, upon
subjecting his purified FMS preparation (UM-2 residueSephadex G-50 BieGel P-10 active eluant peak fraction} to PAGE,
observed a single major protein band.

However, the differ-

ence in results can be attributed to non-identical conditions under which these PAGE analyses were performed.

The

results in this study were dependent upon an electrophoresis
run for a longer period of time and gels that measured 10 ern
in length as opposed to 6.5 ern.

Also, the applied purified

preparation was different in its source.

The purification

scheme applied in this study, may have removed or modified
factors which previously interfered or did not allow full
separation of FMS.
It now appears that previous reports on isolation of
FMS as a polypeptide molecule of assumingly single molecular
form are somewhat premature.

There is little doubt that

this Fat-Mobilizing Substance, 'FMS', consists of three
active variants representing three molecular forms which
are presumably derivatives of the same protein molecule.
It is recognized that the experiments in this study
give less definitive answers regarding the nature of these
three active variants than curiosity desires; however, i t
is hoped that they will draw attention on this subject of
study and cause further experimentation by otherstorealize
the full potential of FMS as possibly part of a physiological homeostatic control of body fat.

SUMNARY
A Fat Mobilzing Substance (FHS) has been prepared
from the urine of fasting rats by a four stage extraction
procedure involving benzoic acid precipitation, water
extraction, alcoholic precipitation and lyophilization.
New approaches were established for testing the lipolytic
activity of FMS in addition to the quantitative release of
free fatty acids (FFA) from epididymal fat pads of the rat
into a medium containing bovine serum albumin.

To avoid

misleading information on the metabolic potential of FMS.
on its target tissue induced by differences in the cellularity of the tissue amongst animals of different body
weight, the cellular na·ture of the tissue employed within
the assay systems was delineated.

An assay system was instituted employing isolated fat
cells and based upon the release of glycerol and FFA from
fat cells of known size and lipid content.

Fat cell pre-

parations were derived solely from rats 130-150 grams in
weight and the mean cell diameter v1as found to be 44u + 10.
The preparations demonstrated a marked degree of diameter
and volume inter-suspension homogeneity.

Therefore, data

wereexpressed in terms FFA released per 10

6

and per unit cell lipid.

target cells

Considerably increased lipolysis

by FMS target cells was observed in all assays utilizing
167

168
isolated fat cells; this was reflected by the sizeable
increased amounts of FFA released in response to the same
FMS preparations initially tested employingintact fat pads
from animals within the same weight range.
For the purpose of removing the inherent problem of
relying on only the one suspect parameter, FFA, as an index
of FMS in vitro lipolysis glycerol release was introduced
as a comparative criterion.

The relationship existing

between the two parameters showed no reesterification of
the FFA had taken place during FMS induced lipolysis and
affirmed that the glycerol released into the medium is produced from triglycerides and not primarily from glycerophosphates or lower glycerides.

A highly positive correlation

was demonstrated between the two methods of assay.
When the lipolytic activity elicited by FMS isolated
from variable weight range and age male rat groups was
studied, it was found that an increase in weight and age
was accompanied by a concomitant decrease in FMS specific
activity and an increase in total activity.
It now appears that previous reports on isolation of
FMS as a polypeptide molecule of assumingly single molecular
form are somewhat premature.

Investigation of FMS with iso-

electric focusing revealed FMS consists of three active
variants representing three molecular forms which are presumably derivatives of the same protein molecule, identifiably:

FMS Fraction I, pi 4.1; FMS Fraction II, pi 4.5; and
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FMS Fraction III, pi 5.1.
FMS Fraction I and II demonstrated identical staining
properties upon densitometric quantitation of their polyacrylamide gels.

FMS Fraction I resolved and separated

into one major (97%) and one small (3%) fast moving subsidary band.

This same FMS doublet having identical staining

·intensity values with identical migration distances-was
also contained in FHS Fraction II.

FHS Frac·tion II gels

displayed an unaccounted for heterogeneity.
FMS Fraction I and II appear to have molecular weights
between 5,000 and 10,000 daltons, display no difference in
specific lipolytic activity, and chemically show identical
protein content (60%).

FMS Fraction III yielded lower

values of specific lipolytic activity per FMS protein and
appears chemically to be a 100% polypeptide of a molecular
weight to the upper range of an approximated molecular
weight of 1,000 to 5,000 daltons.
FMS Fraction I, II, and III were purified by ultrafiltration and column chromatography and isoelectric focusing.

From this study, it is suggested that future purifi-

cations use the following scheme:

(1) initial PM-10 ultra-

filtration of Crude FHS (2) DH-5 ultrafiltration of the PM10 filtrate, followed by (3a) gel filtration on BioGel P-10
of the m1-5 residue to be the most sui table combination of
ultrafiltration and gel filtration for future purification
of FMS Fraction I and II, and (3b) gel filtration of the
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DM-5 ultrafiltrate should be the most suitable for FHS
Fraction III.
A limitation of ultrafiltration and gel filtration in
the isolation and purification of FMS is the inability of
gel filtration to separate FMS Fraction I from FMS Fraction
II.

Their isolation can be achieved by isoelectric focusing

of the DM-5 residue without prior gel filtration.
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